Skip to main content
Erschienen in: Seminars in Immunopathology 5/2014

01.09.2014 | Review

Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus

verfasst von: Tony N. Marion, Arnold E. Postlethwaite

Erschienen in: Seminars in Immunopathology | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Systemic lupus erythematosus (SLE) is a remarkably complex and heterogeneous systemic autoimmune disease. Disease complexity within individuals and heterogeneity among individuals, even genetically identical individuals, is driven by stochastic execution of a complex inherited program. Genome-wide association studies (GWAS) have progressively improved understanding of which genes are most critical to the potential for SLE and provided illuminating insight about the immune mechanisms that are engaged in SLE. What initiates expression of the genetic program to cause SLE within an individual and how that program is initiated remains poorly understood. If we extrapolate from all of the different experimental mouse models for SLE, we can begin to appreciate why SLE is so heterogeneous and consequently why prediction of disease outcome is so difficult. In this review, we critically evaluate extrinsic versus intrinsic cellular functions in the clearance and elimination of cellular debris and how dysfunction in that system may promote autoimmunity to nuclear antigens. We also examine several mouse models genetically prone to SLE either because of natural inheritance or inheritance of induced mutations to illustrate how different immune mechanisms may initiate autoimmunity and affect disease pathogenesis. Finally, we describe the heterogeneity of disease manifestations in SLE and discuss the mechanisms of disease pathogenesis with emphasis on glomerulonephritis. Particular attention is given to discussion of how anti-DNA autoantibody initiates experimental lupus nephritis (LN) in mice.
Literatur
1.
Zurück zum Zitat Kotzin BL (1996) Systemic lupus erythematosus. Cell 85(3):303–306PubMed Kotzin BL (1996) Systemic lupus erythematosus. Cell 85(3):303–306PubMed
2.
Zurück zum Zitat Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y (2004) Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 34(2):501–537PubMed Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y (2004) Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 34(2):501–537PubMed
3.
Zurück zum Zitat Guidelines ACoRAHCoSLE (1999) Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis Rheum 42(9):1785–1796 Guidelines ACoRAHCoSLE (1999) Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis Rheum 42(9):1785–1796
5.
Zurück zum Zitat Stoll T, Seifert B, Isenberg DA (1996) SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 35(3):248–254PubMed Stoll T, Seifert B, Isenberg DA (1996) SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 35(3):248–254PubMed
6.
Zurück zum Zitat Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271–1277PubMed Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271–1277PubMed
7.
Zurück zum Zitat Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sanchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677–2686. doi:10.1002/art.34473 PubMedPubMedCentral Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sanchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64(8):2677–2686. doi:10.​1002/​art.​34473 PubMedPubMedCentral
8.
Zurück zum Zitat Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, Karpouzas GA, Merrill JT, Wallace DJ, Yazdany J, Ramsey-Goldman R, Singh K, Khalighi M, Choi SI, Gogia M, Kafaja S, Kamgar M, Lau C, Martin WJ, Parikh S, Peng J, Rastogi A, Chen W, Grossman JM, American College of R (2012) American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken) 64(6):797–808. doi:10.1002/acr.21664 Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, Karpouzas GA, Merrill JT, Wallace DJ, Yazdany J, Ramsey-Goldman R, Singh K, Khalighi M, Choi SI, Gogia M, Kafaja S, Kamgar M, Lau C, Martin WJ, Parikh S, Peng J, Rastogi A, Chen W, Grossman JM, American College of R (2012) American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken) 64(6):797–808. doi:10.​1002/​acr.​21664
9.
Zurück zum Zitat Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, Dooley MA, Nived O, Sturfelt G, Steinsson K, Alarcon G, Senecal JL, Zummer M, Hanly J, Ensworth S, Pope J, Edworthy S, Rahman A, Sibley J, El-Gabalawy H, McCarthy T, St Pierre Y, Clarke A, Ramsey-Goldman R (2006) Mortality in systemic lupus erythematosus. Arthritis Rheum 54(8):2550–2557. doi:10.1002/art.21955 PubMed Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, Dooley MA, Nived O, Sturfelt G, Steinsson K, Alarcon G, Senecal JL, Zummer M, Hanly J, Ensworth S, Pope J, Edworthy S, Rahman A, Sibley J, El-Gabalawy H, McCarthy T, St Pierre Y, Clarke A, Ramsey-Goldman R (2006) Mortality in systemic lupus erythematosus. Arthritis Rheum 54(8):2550–2557. doi:10.​1002/​art.​21955 PubMed
10.
11.
Zurück zum Zitat Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ (2006) Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25(3):417–428PubMed Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ (2006) Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25(3):417–428PubMed
12.
Zurück zum Zitat Shlomchik M, Mascelli M, Shan H, Radic MZ, Pisetsky D, Marshak-Rothstein A, Weigert M (1990) Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 171:265–297PubMed Shlomchik M, Mascelli M, Shan H, Radic MZ, Pisetsky D, Marshak-Rothstein A, Weigert M (1990) Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 171:265–297PubMed
13.
Zurück zum Zitat Tillman DM, Jou NT, Hill RJ, Marion TN (1992) Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice. J Exp Med 176(3):761–779PubMed Tillman DM, Jou NT, Hill RJ, Marion TN (1992) Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice. J Exp Med 176(3):761–779PubMed
14.
Zurück zum Zitat Tan EM (1989) Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93–151PubMed Tan EM (1989) Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93–151PubMed
16.
Zurück zum Zitat Ward MM (2004) Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: results from the third national health and nutrition examination survey. J Womens Health (Larchmt) 13(6):713–718. doi:10.1089/1540999041783208 Ward MM (2004) Prevalence of physician-diagnosed systemic lupus erythematosus in the United States: results from the third national health and nutrition examination survey. J Womens Health (Larchmt) 13(6):713–718. doi:10.​1089/​1540999041783208​
17.
Zurück zum Zitat Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH, National Arthritis Data W (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I Arthritis Rheum 58(1):15–25. doi:10.1002/art.23177 Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH, National Arthritis Data W (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I Arthritis Rheum 58(1):15–25. doi:10.​1002/​art.​23177
18.
Zurück zum Zitat McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh CK (1995) Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 38(9):1260–1270PubMed McCarty DJ, Manzi S, Medsger TA Jr, Ramsey-Goldman R, LaPorte RE, Kwoh CK (1995) Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum 38(9):1260–1270PubMed
19.
Zurück zum Zitat Contreras G, Lenz O, Pardo V, Borja E, Cely C, Iqbal K, Nahar N, de La Cuesta C, Hurtado A, Fornoni A, Beltran-Garcia L, Asif A, Young L, Diego J, Zachariah M, Smith-Norwood B (2006) Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int 69(10):1846–1851. doi:10.1038/sj.ki.5000243 PubMed Contreras G, Lenz O, Pardo V, Borja E, Cely C, Iqbal K, Nahar N, de La Cuesta C, Hurtado A, Fornoni A, Beltran-Garcia L, Asif A, Young L, Diego J, Zachariah M, Smith-Norwood B (2006) Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int 69(10):1846–1851. doi:10.​1038/​sj.​ki.​5000243 PubMed
20.
Zurück zum Zitat Franco C, Yoo W, Franco D, Xu Z (2010) Predictors of end stage renal disease in African Americans with lupus nephritis. Bull NYU Hosp Jt Dis 68(4):251–256PubMed Franco C, Yoo W, Franco D, Xu Z (2010) Predictors of end stage renal disease in African Americans with lupus nephritis. Bull NYU Hosp Jt Dis 68(4):251–256PubMed
22.
Zurück zum Zitat Tucker LB, Menon S, Schaller JG, Isenberg DA (1995) Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 34(9):866–872PubMed Tucker LB, Menon S, Schaller JG, Isenberg DA (1995) Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 34(9):866–872PubMed
24.
Zurück zum Zitat Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ (1978) Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 148(5):1198–1215PubMed Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ (1978) Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 148(5):1198–1215PubMed
25.
Zurück zum Zitat Rudofsky UH, Evans BD, Balaban SL, Mottironi VD, Gabrielsen AE (1993) Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Lab Invest 68(4):419–426PubMed Rudofsky UH, Evans BD, Balaban SL, Mottironi VD, Gabrielsen AE (1993) Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Lab Invest 68(4):419–426PubMed
26.
Zurück zum Zitat Wakeland EK, Liu K, Graham RR, Behrens TW (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity 15(3):397–408PubMed Wakeland EK, Liu K, Graham RR, Behrens TW (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity 15(3):397–408PubMed
27.
Zurück zum Zitat Howie JB, Helyer BJ (1968) The immunology and pathology of NZB mice. Adv Immunol 9:215–266PubMed Howie JB, Helyer BJ (1968) The immunology and pathology of NZB mice. Adv Immunol 9:215–266PubMed
28.
Zurück zum Zitat Helyer BJ, Howie JB (1963) Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice. Nature 197:197PubMed Helyer BJ, Howie JB (1963) Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice. Nature 197:197PubMed
29.
Zurück zum Zitat Drake CG, Babcock SK, Palmer E, Kotzin BL (1994) Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB x NZW)F1 mice. Proc Natl Acad Sci U S A 91(9):4062–4066PubMedPubMedCentral Drake CG, Babcock SK, Palmer E, Kotzin BL (1994) Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB x NZW)F1 mice. Proc Natl Acad Sci U S A 91(9):4062–4066PubMedPubMedCentral
30.
Zurück zum Zitat Knight JG, Adams DD (1978) Three genes for lupus nephritis in NZB x NZW mice. J Exp Med 147:1653–1660PubMed Knight JG, Adams DD (1978) Three genes for lupus nephritis in NZB x NZW mice. J Exp Med 147:1653–1660PubMed
31.
Zurück zum Zitat Kono DH, Burlingame RW, Owens DG, Kuramochi A, Balderas RS, Balomenos D, Theofilopoulos AN (1994) Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci U S A 91(21):10168–10172PubMedPubMedCentral Kono DH, Burlingame RW, Owens DG, Kuramochi A, Balderas RS, Balomenos D, Theofilopoulos AN (1994) Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci U S A 91(21):10168–10172PubMedPubMedCentral
32.
Zurück zum Zitat Kotzin BL, Palmer E (1987) The contribution of NZW genes to lupus-like disease in (NZB x NZW)F1 mice. J Exp Med 165:1237–1251PubMed Kotzin BL, Palmer E (1987) The contribution of NZW genes to lupus-like disease in (NZB x NZW)F1 mice. J Exp Med 165:1237–1251PubMed
33.
Zurück zum Zitat Morel L, Wakeland EK (1998) Susceptibility to lupus nephritis in the NZB/W model system. Curr Opin Immunol 10(6):718–725PubMed Morel L, Wakeland EK (1998) Susceptibility to lupus nephritis in the NZB/W model system. Curr Opin Immunol 10(6):718–725PubMed
34.
Zurück zum Zitat Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK (1994) Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1(3):219–229PubMed Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK (1994) Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1(3):219–229PubMed
36.
Zurück zum Zitat Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy-Lahad E, Mazzella M, Goulet O, Perroni L, Bricarelli FD, Byrne G, McEuen M, Proll S, Appleby M, Brunkow ME (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27(1):18–20. doi:10.1038/83707 PubMed Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, Levy-Lahad E, Mazzella M, Goulet O, Perroni L, Bricarelli FD, Byrne G, McEuen M, Proll S, Appleby M, Brunkow ME (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27(1):18–20. doi:10.​1038/​83707 PubMed
37.
Zurück zum Zitat Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27(1):20–21. doi:10.1038/83713 PubMed Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27(1):20–21. doi:10.​1038/​83713 PubMed
38.
Zurück zum Zitat Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N (1997) Positional cloning of the APECED gene. Nat Genet 17(4):393–398. doi:10.1038/ng1297-393 PubMed Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N (1997) Positional cloning of the APECED gene. Nat Genet 17(4):393–398. doi:10.​1038/​ng1297-393 PubMed
39.
Zurück zum Zitat Finnish-German AC (1997) An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 17(4):399–403. doi:10.1038/ng1297-399 Finnish-German AC (1997) An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat Genet 17(4):399–403. doi:10.​1038/​ng1297-399
40.
Zurück zum Zitat Ahonen P (1985) Autoimmune polyendocrinopathy–candidosis–ectodermal dystrophy (APECED): autosomal recessive inheritance. Clin Genet 27(6):535–542PubMed Ahonen P (1985) Autoimmune polyendocrinopathy–candidosis–ectodermal dystrophy (APECED): autosomal recessive inheritance. Clin Genet 27(6):535–542PubMed
41.
Zurück zum Zitat Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, Caeiro F, Massardo L, Villa AR, Pons-Estel BA, Grupo Latinoamericano de Estudio del Lupus E (2005) Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 52(4):1138–1147. doi:10.1002/art.20999 PubMed Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, Caeiro F, Massardo L, Villa AR, Pons-Estel BA, Grupo Latinoamericano de Estudio del Lupus E (2005) Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 52(4):1138–1147. doi:10.​1002/​art.​20999 PubMed
42.
Zurück zum Zitat Harley IT, Kaufman KM, Langefeld CD, Harley JB, Kelly JA (2009) Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat Rev Genet 10(5):285–290. doi:10.1038/nrg2571 PubMedPubMedCentral Harley IT, Kaufman KM, Langefeld CD, Harley JB, Kelly JA (2009) Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat Rev Genet 10(5):285–290. doi:10.​1038/​nrg2571 PubMedPubMedCentral
43.
Zurück zum Zitat Block SR, Winfield JB, Lockshin MD, D'Angelo WA, Christian CL (1975) Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Am J Med 59(4):533–552PubMed Block SR, Winfield JB, Lockshin MD, D'Angelo WA, Christian CL (1975) Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Am J Med 59(4):533–552PubMed
44.
Zurück zum Zitat Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, Walker A, Mack TM (1992) A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 35(3):311–318PubMed Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, Walker A, Mack TM (1992) A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 35(3):311–318PubMed
47.
Zurück zum Zitat So HC, Gui AH, Cherny SS, Sham PC (2011) Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet Epidemiol 35(5):310–317. doi:10.1002/gepi.20579 PubMed So HC, Gui AH, Cherny SS, Sham PC (2011) Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet Epidemiol 35(5):310–317. doi:10.​1002/​gepi.​20579 PubMed
50.
Zurück zum Zitat Eisenberg RA, Craven SY, Warren RW, Cohen PL (1987) Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice. J Clin Invest 80(3):691–697PubMedPubMedCentral Eisenberg RA, Craven SY, Warren RW, Cohen PL (1987) Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice. J Clin Invest 80(3):691–697PubMedPubMedCentral
51.
Zurück zum Zitat Gray-McGuire C, Moser KL, Gaffney PM, Kelly J, Yu H, Olson JM, Jedrey CM, Jacobs KB, Kimberly RP, Neas BR, Rich SS, Behrens TW, Harley JB (2000) Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistasis at 4p16-15.2. Am J Hum Genet 67(6):1460–1469. doi:10.1086/316891 PubMedPubMedCentral Gray-McGuire C, Moser KL, Gaffney PM, Kelly J, Yu H, Olson JM, Jedrey CM, Jacobs KB, Kimberly RP, Neas BR, Rich SS, Behrens TW, Harley JB (2000) Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistasis at 4p16-15.2. Am J Hum Genet 67(6):1460–1469. doi:10.​1086/​316891 PubMedPubMedCentral
52.
Zurück zum Zitat Hughes T, Adler A, Kelly JA, Kaufman KM, Williams AH, Langefeld CD, Brown EE, Alarcon GS, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Boackle SA, Stevens AM, Reveille JD, Sanchez E, Martin J, Niewold TB, Vila LM, Scofield RH, Gilkeson GS, Gaffney PM, Criswell LA, Moser KL, Merrill JT, Jacob CO, Tsao BP, James JA, Vyse TJ, Alarcon-Riquelme ME, Network B, Harley JB, Richardson BC, Sawalha AH (2012) Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus. Arthritis Rheum 64(2):485–492. doi:10.1002/art.33354 PubMedPubMedCentral Hughes T, Adler A, Kelly JA, Kaufman KM, Williams AH, Langefeld CD, Brown EE, Alarcon GS, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Boackle SA, Stevens AM, Reveille JD, Sanchez E, Martin J, Niewold TB, Vila LM, Scofield RH, Gilkeson GS, Gaffney PM, Criswell LA, Moser KL, Merrill JT, Jacob CO, Tsao BP, James JA, Vyse TJ, Alarcon-Riquelme ME, Network B, Harley JB, Richardson BC, Sawalha AH (2012) Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus. Arthritis Rheum 64(2):485–492. doi:10.​1002/​art.​33354 PubMedPubMedCentral
53.
Zurück zum Zitat Castillejo-Lopez C, Delgado-Vega AM, Wojcik J, Kozyrev SV, Thavathiru E, Wu YY, Sanchez E, Pollmann D, Lopez-Egido JR, Fineschi S, Dominguez N, Lu R, James JA, Merrill JT, Kelly JA, Kaufman KM, Moser KL, Gilkeson G, Frostegard J, Pons-Estel BA, D'Alfonso S, Witte T, Callejas JL, Harley JB, Gaffney PM, Martin J, Guthridge JM, Alarcon-Riquelme ME (2012) Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK. Ann Rheum Dis 71(1):136–142. doi:10.1136/annrheumdis-2011-200085 PubMedPubMedCentral Castillejo-Lopez C, Delgado-Vega AM, Wojcik J, Kozyrev SV, Thavathiru E, Wu YY, Sanchez E, Pollmann D, Lopez-Egido JR, Fineschi S, Dominguez N, Lu R, James JA, Merrill JT, Kelly JA, Kaufman KM, Moser KL, Gilkeson G, Frostegard J, Pons-Estel BA, D'Alfonso S, Witte T, Callejas JL, Harley JB, Gaffney PM, Martin J, Guthridge JM, Alarcon-Riquelme ME (2012) Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK. Ann Rheum Dis 71(1):136–142. doi:10.​1136/​annrheumdis-2011-200085 PubMedPubMedCentral
54.
Zurück zum Zitat Dang J, Shan S, Li J, Zhao H, Xin Q, Liu Y, Bian X, Liu Q (2014) Gene-gene interactions of IRF5, STAT4, IKZF1 and ETS1 in systemic lupus erythematosus. Tissue Antigens 83(6):401–408. doi:10.1111/tan.12349 PubMed Dang J, Shan S, Li J, Zhao H, Xin Q, Liu Y, Bian X, Liu Q (2014) Gene-gene interactions of IRF5, STAT4, IKZF1 and ETS1 in systemic lupus erythematosus. Tissue Antigens 83(6):401–408. doi:10.​1111/​tan.​12349 PubMed
55.
Zurück zum Zitat Leng RX, Wang W, Cen H, Zhou M, Feng CC, Zhu Y, Yang XK, Yang M, Zhai Y, Li BZ, Wang XS, Li R, Chen GM, Chen H, Pan HF, Ye DQ (2012) Gene-gene and gene-sex epistatic interactions of MiR146a, IRF5, IKZF1, ETS1 and IL21 in systemic lupus erythematosus. PLoS ONE 7(12):e51090. doi:10.1371/journal.pone.0051090 PubMedPubMedCentral Leng RX, Wang W, Cen H, Zhou M, Feng CC, Zhu Y, Yang XK, Yang M, Zhai Y, Li BZ, Wang XS, Li R, Chen GM, Chen H, Pan HF, Ye DQ (2012) Gene-gene and gene-sex epistatic interactions of MiR146a, IRF5, IKZF1, ETS1 and IL21 in systemic lupus erythematosus. PLoS ONE 7(12):e51090. doi:10.​1371/​journal.​pone.​0051090 PubMedPubMedCentral
56.
Zurück zum Zitat Javierre BM, Fernandez AF, Richter J, Al-Shahrour F, Martin-Subero JI, Rodriguez-Ubreva J, Berdasco M, Fraga MF, O'Hanlon TP, Rider LG, Jacinto FV, Lopez-Longo FJ, Dopazo J, Forn M, Peinado MA, Carreno L, Sawalha AH, Harley JB, Siebert R, Esteller M, Miller FW, Ballestar E (2010) Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 20(2):170–179. doi:10.1101/gr.100289.109 PubMedPubMedCentral Javierre BM, Fernandez AF, Richter J, Al-Shahrour F, Martin-Subero JI, Rodriguez-Ubreva J, Berdasco M, Fraga MF, O'Hanlon TP, Rider LG, Jacinto FV, Lopez-Longo FJ, Dopazo J, Forn M, Peinado MA, Carreno L, Sawalha AH, Harley JB, Siebert R, Esteller M, Miller FW, Ballestar E (2010) Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 20(2):170–179. doi:10.​1101/​gr.​100289.​109 PubMedPubMedCentral
57.
Zurück zum Zitat Ballestar E, Esteller M, Richardson BC (2006) The epigenetic face of systemic lupus erythematosus. J Immunol 176(12):7143–7147PubMed Ballestar E, Esteller M, Richardson BC (2006) The epigenetic face of systemic lupus erythematosus. J Immunol 176(12):7143–7147PubMed
58.
Zurück zum Zitat James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB (1997) An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 100(12):3019–3026. doi:10.1172/JCI119856 PubMedPubMedCentral James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB (1997) An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 100(12):3019–3026. doi:10.​1172/​JCI119856 PubMedPubMedCentral
60.
Zurück zum Zitat Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19(1):56–59. doi:10.1038/ng0598-56 PubMed Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19(1):56–59. doi:10.​1038/​ng0598-56 PubMed
61.
Zurück zum Zitat Mazur DJ, Perrino FW (1999) Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian 3′→5′ exonucleases. J Biol Chem 274(28):19655–19660PubMed Mazur DJ, Perrino FW (1999) Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian 3′→5′ exonucleases. J Biol Chem 274(28):19655–19660PubMed
62.
Zurück zum Zitat Lee-Kirsch MA, Gong M, Chowdhury D, Senenko L, Engel K, Lee YA, de Silva U, Bailey SL, Witte T, Vyse TJ, Kere J, Pfeiffer C, Harvey S, Wong A, Koskenmies S, Hummel O, Rohde K, Schmidt RE, Dominiczak AF, Gahr M, Hollis T, Perrino FW, Lieberman J, Hubner N (2007) Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 39(9):1065–1067. doi:10.1038/ng2091 PubMed Lee-Kirsch MA, Gong M, Chowdhury D, Senenko L, Engel K, Lee YA, de Silva U, Bailey SL, Witte T, Vyse TJ, Kere J, Pfeiffer C, Harvey S, Wong A, Koskenmies S, Hummel O, Rohde K, Schmidt RE, Dominiczak AF, Gahr M, Hollis T, Perrino FW, Lieberman J, Hubner N (2007) Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 39(9):1065–1067. doi:10.​1038/​ng2091 PubMed
64.
Zurück zum Zitat Hashimoto H, Tsuda H, Matsumoto T, Nasu H, Takasaki Y, Shokawa Y, Hirose S, Terasaki PI, Iwaki Y (1985) HLA antigens associated with systemic lupus erythematosus in Japan. J Rheumatol 12(5):919–923PubMed Hashimoto H, Tsuda H, Matsumoto T, Nasu H, Takasaki Y, Shokawa Y, Hirose S, Terasaki PI, Iwaki Y (1985) HLA antigens associated with systemic lupus erythematosus in Japan. J Rheumatol 12(5):919–923PubMed
67.
Zurück zum Zitat Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ (2000) Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 76:227–324PubMed Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ (2000) Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 76:227–324PubMed
68.
Zurück zum Zitat Sullivan KE (1998) Complement deficiency and autoimmunity. Curr Opin Pediatr 10(6):600–606PubMed Sullivan KE (1998) Complement deficiency and autoimmunity. Curr Opin Pediatr 10(6):600–606PubMed
72.
Zurück zum Zitat Chung SA, Taylor KE, Graham RR, Nititham J, Lee AT, Ortmann WA, Jacob CO, Alarcon-Riquelme ME, Tsao BP, Harley JB, Gaffney PM, Moser KL, Petri M, Demirci FY, Kamboh MI, Manzi S, Gregersen PK, Langefeld CD, Behrens TW, Criswell LA (2011) Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet 7(3):e1001323. doi:10.1371/journal.pgen.1001323 PubMedPubMedCentral Chung SA, Taylor KE, Graham RR, Nititham J, Lee AT, Ortmann WA, Jacob CO, Alarcon-Riquelme ME, Tsao BP, Harley JB, Gaffney PM, Moser KL, Petri M, Demirci FY, Kamboh MI, Manzi S, Gregersen PK, Langefeld CD, Behrens TW, Criswell LA (2011) Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production. PLoS Genet 7(3):e1001323. doi:10.​1371/​journal.​pgen.​1001323 PubMedPubMedCentral
73.
Zurück zum Zitat Yang W, Shen N, Ye DQ, Liu Q, Zhang Y, Qian XX, Hirankarn N, Ying D, Pan HF, Mok CC, Chan TM, Wong RW, Lee KW, Mok MY, Wong SN, Leung AM, Li XP, Avihingsanon Y, Wong CM, Lee TL, Ho MH, Lee PP, Chang YK, Li PH, Li RJ, Zhang L, Wong WH, Ng IO, Lau CS, Sham PC, Lau YL (2010) Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet 6(2):e1000841. doi:10.1371/journal.pgen.1000841 PubMedPubMedCentral Yang W, Shen N, Ye DQ, Liu Q, Zhang Y, Qian XX, Hirankarn N, Ying D, Pan HF, Mok CC, Chan TM, Wong RW, Lee KW, Mok MY, Wong SN, Leung AM, Li XP, Avihingsanon Y, Wong CM, Lee TL, Ho MH, Lee PP, Chang YK, Li PH, Li RJ, Zhang L, Wong WH, Ng IO, Lau CS, Sham PC, Lau YL (2010) Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet 6(2):e1000841. doi:10.​1371/​journal.​pgen.​1000841 PubMedPubMedCentral
74.
Zurück zum Zitat Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, Tsao BP, Vyse TJ, Langefeld CD, Nath SK, Guthridge JM, Cobb BL, Mirel DB, Marion MC, Williams AH, Divers J, Wang W, Frank SG, Namjou B, Gabriel SB, Lee AT, Gregersen PK, Behrens TW, Taylor KE, Fernando M, Zidovetzki R, Gaffney PM, Edberg JC, Rioux JD, Ojwang JO, James JA, Merrill JT, Gilkeson GS, Seldin MF, Yin H, Baechler EC, Li QZ, Wakeland EK, Bruner GR, Kaufman KM, Kelly JA (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40(2):204–210. doi:10.1038/ng.81 PubMedPubMedCentral Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, Tsao BP, Vyse TJ, Langefeld CD, Nath SK, Guthridge JM, Cobb BL, Mirel DB, Marion MC, Williams AH, Divers J, Wang W, Frank SG, Namjou B, Gabriel SB, Lee AT, Gregersen PK, Behrens TW, Taylor KE, Fernando M, Zidovetzki R, Gaffney PM, Edberg JC, Rioux JD, Ojwang JO, James JA, Merrill JT, Gilkeson GS, Seldin MF, Yin H, Baechler EC, Li QZ, Wakeland EK, Bruner GR, Kaufman KM, Kelly JA (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40(2):204–210. doi:10.​1038/​ng.​81 PubMedPubMedCentral
75.
Zurück zum Zitat Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S, Lee AT, Chung SA, Ferreira RC, Pant PV, Ballinger DG, Kosoy R, Demirci FY, Kamboh MI, Kao AH, Tian C, Gunnarsson I, Bengtsson AA, Rantapaa-Dahlqvist S, Petri M, Manzi S, Seldin MF, Ronnblom L, Syvanen AC, Criswell LA, Gregersen PK, Behrens TW (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358(9):900–909. doi:10.1056/NEJMoa0707865 PubMed Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S, Lee AT, Chung SA, Ferreira RC, Pant PV, Ballinger DG, Kosoy R, Demirci FY, Kamboh MI, Kao AH, Tian C, Gunnarsson I, Bengtsson AA, Rantapaa-Dahlqvist S, Petri M, Manzi S, Seldin MF, Ronnblom L, Syvanen AC, Criswell LA, Gregersen PK, Behrens TW (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 358(9):900–909. doi:10.​1056/​NEJMoa0707865 PubMed
76.
Zurück zum Zitat Sekine H, Ferreira RC, Pan-Hammarstrom Q, Graham RR, Ziemba B, de Vries SS, Liu J, Hippen K, Koeuth T, Ortmann W, Iwahori A, Elliott MK, Offer S, Skon C, Du L, Novitzke J, Lee AT, Zhao N, Tompkins JD, Altshuler D, Gregersen PK, Cunningham-Rundles C, Harris RS, Her C, Nelson DL, Hammarstrom L, Gilkeson GS, Behrens TW (2007) Role for Msh5 in the regulation of Ig class switch recombination. Proc Natl Acad Sci U S A 104(17):7193–7198. doi:10.1073/pnas.0700815104 PubMedPubMedCentral Sekine H, Ferreira RC, Pan-Hammarstrom Q, Graham RR, Ziemba B, de Vries SS, Liu J, Hippen K, Koeuth T, Ortmann W, Iwahori A, Elliott MK, Offer S, Skon C, Du L, Novitzke J, Lee AT, Zhao N, Tompkins JD, Altshuler D, Gregersen PK, Cunningham-Rundles C, Harris RS, Her C, Nelson DL, Hammarstrom L, Gilkeson GS, Behrens TW (2007) Role for Msh5 in the regulation of Ig class switch recombination. Proc Natl Acad Sci U S A 104(17):7193–7198. doi:10.​1073/​pnas.​0700815104 PubMedPubMedCentral
77.
78.
Zurück zum Zitat Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R, Barohn RJ, Saperstein DS, Briemberg HR, Ericsson M, Park P, Amato AA (2005) Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 57(5):664–678. doi:10.1002/ana.20464 PubMed Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R, Barohn RJ, Saperstein DS, Briemberg HR, Ericsson M, Park P, Amato AA (2005) Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 57(5):664–678. doi:10.​1002/​ana.​20464 PubMed
79.
Zurück zum Zitat Baechler EC, Bauer JW, Slattery CA, Ortmann WA, Espe KJ, Novitzke J, Ytterberg SR, Gregersen PK, Behrens TW, Reed AM (2007) An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity. Mol Med 13(1–2):59–68. doi:10.2119/2006-00085.Baechler PubMedPubMedCentral Baechler EC, Bauer JW, Slattery CA, Ortmann WA, Espe KJ, Novitzke J, Ytterberg SR, Gregersen PK, Behrens TW, Reed AM (2007) An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity. Mol Med 13(1–2):59–68. doi:10.​2119/​2006-00085.​Baechler PubMedPubMedCentral
80.
Zurück zum Zitat Braunstein I, Klein R, Okawa J, Werth VP (2012) The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score. Br J Dermatol 166(5):971–975. doi:10.1111/j.1365-2133.2012.10825.x PubMedPubMedCentral Braunstein I, Klein R, Okawa J, Werth VP (2012) The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score. Br J Dermatol 166(5):971–975. doi:10.​1111/​j.​1365-2133.​2012.​10825.​x PubMedPubMedCentral
81.
Zurück zum Zitat Irvine KM, Gallego P, An X, Best SE, Thomas G, Wells C, Harris M, Cotterill A, Thomas R (2012) Peripheral blood monocyte gene expression profile clinically stratifies patients with recent-onset type 1 diabetes. Diabetes 61(5):1281–1290. doi:10.2337/db11-1549 PubMedPubMedCentral Irvine KM, Gallego P, An X, Best SE, Thomas G, Wells C, Harris M, Cotterill A, Thomas R (2012) Peripheral blood monocyte gene expression profile clinically stratifies patients with recent-onset type 1 diabetes. Diabetes 61(5):1281–1290. doi:10.​2337/​db11-1549 PubMedPubMedCentral
82.
Zurück zum Zitat Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, Shark KB, Grande WJ, Hughes KM, Kapur V, Gregersen PK, Behrens TW (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100(5):2610–2615. doi:10.1073/pnas.0337679100 PubMedPubMedCentral Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, Shark KB, Grande WJ, Hughes KM, Kapur V, Gregersen PK, Behrens TW (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 100(5):2610–2615. doi:10.​1073/​pnas.​0337679100 PubMedPubMedCentral
85.
87.
Zurück zum Zitat Morimoto AM, Flesher DT, Yang J, Wolslegel K, Wang X, Brady A, Abbas AR, Quarmby V, Wakshull E, Richardson B, Townsend MJ, Behrens TW (2011) Association of endogenous anti-interferon-alpha autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 63(8):2407–2415. doi:10.1002/art.30399 PubMedPubMedCentral Morimoto AM, Flesher DT, Yang J, Wolslegel K, Wang X, Brady A, Abbas AR, Quarmby V, Wakshull E, Richardson B, Townsend MJ, Behrens TW (2011) Association of endogenous anti-interferon-alpha autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 63(8):2407–2415. doi:10.​1002/​art.​30399 PubMedPubMedCentral
88.
Zurück zum Zitat Cunninghame Graham DS, Graham RR, Manku H, Wong AK, Whittaker JC, Gaffney PM, Moser KL, Rioux JD, Altshuler D, Behrens TW, Vyse TJ (2008) Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus. Nat Genet 40(1):83–89. doi:10.1038/ng.2007.47 PubMedPubMedCentral Cunninghame Graham DS, Graham RR, Manku H, Wong AK, Whittaker JC, Gaffney PM, Moser KL, Rioux JD, Altshuler D, Behrens TW, Vyse TJ (2008) Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus. Nat Genet 40(1):83–89. doi:10.​1038/​ng.​2007.​47 PubMedPubMedCentral
89.
Zurück zum Zitat Ohshima Y, Tanaka Y, Tozawa H, Takahashi Y, Maliszewski C, Delespesse G (1997) Expression and function of OX40 ligand on human dendritic cells. J Immunol 159(8):3838–3848PubMed Ohshima Y, Tanaka Y, Tozawa H, Takahashi Y, Maliszewski C, Delespesse G (1997) Expression and function of OX40 ligand on human dendritic cells. J Immunol 159(8):3838–3848PubMed
90.
Zurück zum Zitat Latza U, Durkop H, Schnittger S, Ringeling J, Eitelbach F, Hummel M, Fonatsch C, Stein H (1994) The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen. Eur J Immunol 24(3):677–683. doi:10.1002/eji.1830240329 PubMed Latza U, Durkop H, Schnittger S, Ringeling J, Eitelbach F, Hummel M, Fonatsch C, Stein H (1994) The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen. Eur J Immunol 24(3):677–683. doi:10.​1002/​eji.​1830240329 PubMed
91.
92.
Zurück zum Zitat Chong WP, Ip WK, Wong WH, Lau CS, Chan TM, Lau YL (2004) Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes and Immunity 5(6):484–492. doi:10.1038/sj.gene.6364119 PubMed Chong WP, Ip WK, Wong WH, Lau CS, Chan TM, Lau YL (2004) Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes and Immunity 5(6):484–492. doi:10.​1038/​sj.​gene.​6364119 PubMed
93.
Zurück zum Zitat Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW (1998) Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A 95(16):9465–9470PubMedPubMedCentral Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW (1998) Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A 95(16):9465–9470PubMedPubMedCentral
94.
Zurück zum Zitat Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WE, Hutchinson IV (1997) Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 24(12):2314–2317PubMed Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WE, Hutchinson IV (1997) Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 24(12):2314–2317PubMed
95.
Zurück zum Zitat Sawalha AH, Webb R, Han S, Kelly JA, Kaufman KM, Kimberly RP, Alarcon-Riquelme ME, James JA, Vyse TJ, Gilkeson GS, Choi CB, Scofield RH, Bae SC, Nath SK, Harley JB (2008) Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS ONE 3(3):e1727. doi:10.1371/journal.pone.0001727 PubMedPubMedCentral Sawalha AH, Webb R, Han S, Kelly JA, Kaufman KM, Kimberly RP, Alarcon-Riquelme ME, James JA, Vyse TJ, Gilkeson GS, Choi CB, Scofield RH, Bae SC, Nath SK, Harley JB (2008) Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS ONE 3(3):e1727. doi:10.​1371/​journal.​pone.​0001727 PubMedPubMedCentral
96.
Zurück zum Zitat Hughes T, Kim-Howard X, Kelly JA, Kaufman KM, Langefeld CD, Ziegler J, Sanchez E, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Martin J, Brown EE, Vila LM, Alarcon GS, James JA, Gilkeson GS, Moser KL, Gaffney PM, Merrill JT, Vyse TJ, Alarcon-Riquelme ME, Network B, Nath SK, Harley JB, Sawalha AH (2011) Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21. Arthritis Rheum 63(6):1689–1697. doi:10.1002/art.30320 PubMedPubMedCentral Hughes T, Kim-Howard X, Kelly JA, Kaufman KM, Langefeld CD, Ziegler J, Sanchez E, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Martin J, Brown EE, Vila LM, Alarcon GS, James JA, Gilkeson GS, Moser KL, Gaffney PM, Merrill JT, Vyse TJ, Alarcon-Riquelme ME, Network B, Nath SK, Harley JB, Sawalha AH (2011) Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21. Arthritis Rheum 63(6):1689–1697. doi:10.​1002/​art.​30320 PubMedPubMedCentral
97.
Zurück zum Zitat Cunninghame Graham DS, Wong AK, McHugh NJ, Whittaker JC, Vyse TJ (2006) Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study. Hum Mol Genet 15(21):3195–3205. doi:10.1093/hmg/ddl395 PubMed Cunninghame Graham DS, Wong AK, McHugh NJ, Whittaker JC, Vyse TJ (2006) Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study. Hum Mol Genet 15(21):3195–3205. doi:10.​1093/​hmg/​ddl395 PubMed
98.
Zurück zum Zitat Namjou B, Kothari PH, Kelly JA, Glenn SB, Ojwang JO, Adler A, Alarcon-Riquelme ME, Gallant CJ, Boackle SA, Criswell LA, Kimberly RP, Brown E, Edberg J, Stevens AM, Jacob CO, Tsao BP, Gilkeson GS, Kamen DL, Merrill JT, Petri M, Goldman RR, Vila LM, Anaya JM, Niewold TB, Martin J, Pons-Estel BA, Sabio JM, Callejas JL, Vyse TJ, Bae SC, Perrino FW, Freedman BI, Scofield RH, Moser KL, Gaffney PM, James JA, Langefeld CD, Kaufman KM, Harley JB, Atkinson JP (2011) Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun 12(4):270–279. doi:10.1038/gene.2010.73 PubMedPubMedCentral Namjou B, Kothari PH, Kelly JA, Glenn SB, Ojwang JO, Adler A, Alarcon-Riquelme ME, Gallant CJ, Boackle SA, Criswell LA, Kimberly RP, Brown E, Edberg J, Stevens AM, Jacob CO, Tsao BP, Gilkeson GS, Kamen DL, Merrill JT, Petri M, Goldman RR, Vila LM, Anaya JM, Niewold TB, Martin J, Pons-Estel BA, Sabio JM, Callejas JL, Vyse TJ, Bae SC, Perrino FW, Freedman BI, Scofield RH, Moser KL, Gaffney PM, James JA, Langefeld CD, Kaufman KM, Harley JB, Atkinson JP (2011) Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun 12(4):270–279. doi:10.​1038/​gene.​2010.​73 PubMedPubMedCentral
100.
Zurück zum Zitat Gaipl US, Beyer TD, Heyder P, Kuenkele S, Bottcher A, Voll RE, Kalden JR, Herrmann M (2004) Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin. Arthritis Rheum 50(2):640–649. doi:10.1002/art.20034 PubMed Gaipl US, Beyer TD, Heyder P, Kuenkele S, Bottcher A, Voll RE, Kalden JR, Herrmann M (2004) Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin. Arthritis Rheum 50(2):640–649. doi:10.​1002/​art.​20034 PubMed
101.
Zurück zum Zitat Korb LC, Ahearn JM (1997) C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol 158(10):4525–4528PubMed Korb LC, Ahearn JM (1997) C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol 158(10):4525–4528PubMed
102.
Zurück zum Zitat Sellar GC, Cockburn D, Reid KB (1992) Localization of the gene cluster encoding the A, B, and C chains of human C1q to 1p34.1-1p36.3. Immunogenetics 35(3):214–216PubMed Sellar GC, Cockburn D, Reid KB (1992) Localization of the gene cluster encoding the A, B, and C chains of human C1q to 1p34.1-1p36.3. Immunogenetics 35(3):214–216PubMed
103.
Zurück zum Zitat Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Moroy T (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25(2):177–181PubMed Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Moroy T (2000) Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25(2):177–181PubMed
104.
Zurück zum Zitat Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL, Earp HS, Matsushima GK (2001) Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411(6834):207–211PubMed Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL, Earp HS, Matsushima GK (2001) Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411(6834):207–211PubMed
107.
Zurück zum Zitat Russell PJ, Steinberg AD (1983) Studies of peritoneal macrophage function in mice with systemic lupus erythematosus: depressed phagocytosis of opsonized sheep erythrocytes in vitro. Clin Immunol Immunopathol 27(3):387–402PubMed Russell PJ, Steinberg AD (1983) Studies of peritoneal macrophage function in mice with systemic lupus erythematosus: depressed phagocytosis of opsonized sheep erythrocytes in vitro. Clin Immunol Immunopathol 27(3):387–402PubMed
108.
Zurück zum Zitat Russell PJ, Cameron FH (1986) Studies of macrophage function in murine systemic lupus erythematosus. 3. The nature, anatomical location, and reversibility of the phagocytic defect. J Leukoc Biol 39(1):49–62PubMed Russell PJ, Cameron FH (1986) Studies of macrophage function in murine systemic lupus erythematosus. 3. The nature, anatomical location, and reversibility of the phagocytic defect. J Leukoc Biol 39(1):49–62PubMed
109.
Zurück zum Zitat Fournie GJ, Izui S, Lambert PH, Conte JJ (1976) Genesis and pathogenicity of anti-DNA antibodies. Adv Nephrol Necker Hosp 6:47–61PubMed Fournie GJ, Izui S, Lambert PH, Conte JJ (1976) Genesis and pathogenicity of anti-DNA antibodies. Adv Nephrol Necker Hosp 6:47–61PubMed
110.
Zurück zum Zitat Izui S, Kobayakawa T, Zryd MJ, Louis J, Lambert PH (1977) Mechanism for induction of anti-DNA antibodies by bacterial lipopolysaccharides in mice; II. Correlation between anti-DNA induction and polyclonal antibody formation by various polyclonal B lymphocyte activators. J Immunol 119(6):2157–2162PubMed Izui S, Kobayakawa T, Zryd MJ, Louis J, Lambert PH (1977) Mechanism for induction of anti-DNA antibodies by bacterial lipopolysaccharides in mice; II. Correlation between anti-DNA induction and polyclonal antibody formation by various polyclonal B lymphocyte activators. J Immunol 119(6):2157–2162PubMed
111.
Zurück zum Zitat Izui S, Lambert PH, Fournie GJ, Turler H, Miescher PA (1977) Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharides: identification of circulating DNA and renal localization of DNA-anti-DNA complexes. J Exp Med 145(5):1115–1130PubMed Izui S, Lambert PH, Fournie GJ, Turler H, Miescher PA (1977) Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharides: identification of circulating DNA and renal localization of DNA-anti-DNA complexes. J Exp Med 145(5):1115–1130PubMed
112.
Zurück zum Zitat Munoz LE, Janko C, Grossmayer GE, Frey B, Voll RE, Kern P, Kalden JR, Schett G, Fietkau R, Herrmann M, Gaipl US (2009) Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum 60(6):1733–1742. doi:10.1002/art.24535 PubMed Munoz LE, Janko C, Grossmayer GE, Frey B, Voll RE, Kern P, Kalden JR, Schett G, Fietkau R, Herrmann M, Gaipl US (2009) Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum 60(6):1733–1742. doi:10.​1002/​art.​24535 PubMed
113.
Zurück zum Zitat Rhodes B, Furnrohr BG, Roberts AL, Tzircotis G, Schett G, Spector TD, Vyse TJ (2012) The rs1143679 (R77H) lupus associated variant of ITGAM (CD11b) impairs complement receptor 3 mediated functions in human monocytes. Ann Rheum Dis 71(12):2028–2034. doi:10.1136/annrheumdis-2012-201390 PubMedPubMedCentral Rhodes B, Furnrohr BG, Roberts AL, Tzircotis G, Schett G, Spector TD, Vyse TJ (2012) The rs1143679 (R77H) lupus associated variant of ITGAM (CD11b) impairs complement receptor 3 mediated functions in human monocytes. Ann Rheum Dis 71(12):2028–2034. doi:10.​1136/​annrheumdis-2012-201390 PubMedPubMedCentral
114.
Zurück zum Zitat Fossati-Jimack L, Ling GS, Cortini A, Szajna M, Malik TH, McDonald JU, Pickering MC, Cook HT, Taylor PR, Botto M (2013) Phagocytosis is the main CR3-mediated function affected by the lupus-associated variant of CD11b in human myeloid cells. PLoS ONE 8(2):e57082. doi:10.1371/journal.pone.0057082 PubMedPubMedCentral Fossati-Jimack L, Ling GS, Cortini A, Szajna M, Malik TH, McDonald JU, Pickering MC, Cook HT, Taylor PR, Botto M (2013) Phagocytosis is the main CR3-mediated function affected by the lupus-associated variant of CD11b in human myeloid cells. PLoS ONE 8(2):e57082. doi:10.​1371/​journal.​pone.​0057082 PubMedPubMedCentral
115.
Zurück zum Zitat Bolland S, Ravetch JV (2000) Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13(2):277–285PubMed Bolland S, Ravetch JV (2000) Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13(2):277–285PubMed
116.
Zurück zum Zitat Linterman MA, Rigby RJ, Wong RK, Yu D, Brink R, Cannons JL, Schwartzberg PL, Cook MC, Walters GD, Vinuesa CG (2009) Follicular helper T cells are required for systemic autoimmunity. J Exp Med 206(3):561–576. doi:10.1084/jem.20081886 PubMedPubMedCentral Linterman MA, Rigby RJ, Wong RK, Yu D, Brink R, Cannons JL, Schwartzberg PL, Cook MC, Walters GD, Vinuesa CG (2009) Follicular helper T cells are required for systemic autoimmunity. J Exp Med 206(3):561–576. doi:10.​1084/​jem.​20081886 PubMedPubMedCentral
117.
Zurück zum Zitat Vinuesa CG, Cook MC, Angelucci C, Athanasopoulos V, Rui L, Hill KM, Yu D, Domaschenz H, Whittle B, Lambe T, Roberts IS, Copley RR, Bell JI, Cornall RJ, Goodnow CC (2005) A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435(7041):452–458PubMed Vinuesa CG, Cook MC, Angelucci C, Athanasopoulos V, Rui L, Hill KM, Yu D, Domaschenz H, Whittle B, Lambe T, Roberts IS, Copley RR, Bell JI, Cornall RJ, Goodnow CC (2005) A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435(7041):452–458PubMed
118.
Zurück zum Zitat Chan VW, Meng F, Soriano P, DeFranco AL, Lowell CA (1997) Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7(1):69–81PubMed Chan VW, Meng F, Soriano P, DeFranco AL, Lowell CA (1997) Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7(1):69–81PubMed
119.
Zurück zum Zitat Hibbs ML, Tarlinton DM, Armes J, Grail D, Hodgson G, Maglitto R, Stacker SA, Dunn AR (1995) Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83(2):301–311PubMed Hibbs ML, Tarlinton DM, Armes J, Grail D, Hodgson G, Maglitto R, Stacker SA, Dunn AR (1995) Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83(2):301–311PubMed
120.
Zurück zum Zitat Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Ilic D, Mori S, Watanabe T, Yamamoto T (1995) Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3(5):549–560PubMed Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Ilic D, Mori S, Watanabe T, Yamamoto T (1995) Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3(5):549–560PubMed
121.
Zurück zum Zitat Cornall RJ, Cyster JG, Hibbs ML, Dunn AR, Otipoby KL, Clark EA, Goodnow CC (1998) Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8(4):497–508PubMed Cornall RJ, Cyster JG, Hibbs ML, Dunn AR, Otipoby KL, Clark EA, Goodnow CC (1998) Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8(4):497–508PubMed
122.
Zurück zum Zitat O'Keefe TL, Williams GT, Batista FD, Neuberger MS (1999) Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med 189(8):1307–1313PubMedPubMedCentral O'Keefe TL, Williams GT, Batista FD, Neuberger MS (1999) Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med 189(8):1307–1313PubMedPubMedCentral
123.
Zurück zum Zitat Portanova JP, Claman HN, Kotzin BL (1985) Autoimmunization in murine graft-vs-host disease. I. Selective production of antibodies to histones and DNA. J Immunol 135(6):3850–3856PubMed Portanova JP, Claman HN, Kotzin BL (1985) Autoimmunization in murine graft-vs-host disease. I. Selective production of antibodies to histones and DNA. J Immunol 135(6):3850–3856PubMed
124.
Zurück zum Zitat Gleichmann E, Van Elven EH, Van der Veen JP (1982) A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur J Immunol 12(2):152–159. doi:10.1002/eji.1830120210 PubMed Gleichmann E, Van Elven EH, Van der Veen JP (1982) A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur J Immunol 12(2):152–159. doi:10.​1002/​eji.​1830120210 PubMed
125.
Zurück zum Zitat Morris SC, Cheek RL, Cohen PL, Eisenberg RA (1990) Autoantibodies in chronic graft versus host result from cognate T-B interactions. J Exp Med 171(2):503–517PubMed Morris SC, Cheek RL, Cohen PL, Eisenberg RA (1990) Autoantibodies in chronic graft versus host result from cognate T-B interactions. J Exp Med 171(2):503–517PubMed
126.
Zurück zum Zitat Satoh M, Reeves WH (1994) Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med 180(6):2341–2346PubMed Satoh M, Reeves WH (1994) Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med 180(6):2341–2346PubMed
127.
Zurück zum Zitat Lee PY, Weinstein JS, Nacionales DC, Scumpia PO, Li Y, Butfiloski E, van Rooijen N, Moldawer L, Satoh M, Reeves WH (2008) A novel type I IFN-producing cell subset in murine lupus. J Immunol 180(7):5101–5108PubMedPubMedCentral Lee PY, Weinstein JS, Nacionales DC, Scumpia PO, Li Y, Butfiloski E, van Rooijen N, Moldawer L, Satoh M, Reeves WH (2008) A novel type I IFN-producing cell subset in murine lupus. J Immunol 180(7):5101–5108PubMedPubMedCentral
128.
Zurück zum Zitat Desai DD, Marion TN (2000) Induction of anti-DNA antibody with DNA-peptide complexes. Int Immunol 12(11):1569–1578PubMed Desai DD, Marion TN (2000) Induction of anti-DNA antibody with DNA-peptide complexes. Int Immunol 12(11):1569–1578PubMed
129.
Zurück zum Zitat Desai DD, Krishnan MR, Swindle JT, Marion TN (1993) Antigen-specific induction of antibodies against native mammalian DNA in nonautoimmune mice. J Immunol 151(3):1614–1626PubMed Desai DD, Krishnan MR, Swindle JT, Marion TN (1993) Antigen-specific induction of antibodies against native mammalian DNA in nonautoimmune mice. J Immunol 151(3):1614–1626PubMed
132.
Zurück zum Zitat Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416(6881):603–607PubMed Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416(6881):603–607PubMed
133.
Zurück zum Zitat Webb R, Wren JD, Jeffries M, Kelly JA, Kaufman KM, Tang Y, Frank MB, Merrill J, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Alarcon GS, Vila LM, Alarcon-Riquelme ME, James JA, Vyse TJ, Moser KL, Gaffney PM, Gilkeson GS, Harley JB, Sawalha AH (2009) Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. Arthritis Rheum 60(4):1076–1084. doi:10.1002/art.24360 PubMedPubMedCentral Webb R, Wren JD, Jeffries M, Kelly JA, Kaufman KM, Tang Y, Frank MB, Merrill J, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Alarcon GS, Vila LM, Alarcon-Riquelme ME, James JA, Vyse TJ, Moser KL, Gaffney PM, Gilkeson GS, Harley JB, Sawalha AH (2009) Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. Arthritis Rheum 60(4):1076–1084. doi:10.​1002/​art.​24360 PubMedPubMedCentral
134.
Zurück zum Zitat Goodnow CC (1996) Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci U S A 93(6):2264–2271PubMedPubMedCentral Goodnow CC (1996) Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci U S A 93(6):2264–2271PubMedPubMedCentral
135.
Zurück zum Zitat Krishnan MR, Marion TN (1998) Comparison of the frequencies of arginines in heavy chain CDR3 of antibodies expressed in the primary B-cell repertoires of autoimmune-prone and normal mice. Scand J Immunol 48(3):223–232PubMed Krishnan MR, Marion TN (1998) Comparison of the frequencies of arginines in heavy chain CDR3 of antibodies expressed in the primary B-cell repertoires of autoimmune-prone and normal mice. Scand J Immunol 48(3):223–232PubMed
136.
Zurück zum Zitat Christensen SR, Shlomchik MJ (2007) Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Semin Immunol 19(1):11–23PubMedPubMedCentral Christensen SR, Shlomchik MJ (2007) Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Semin Immunol 19(1):11–23PubMedPubMedCentral
137.
Zurück zum Zitat Lam GK, Petri M (2005) Assessment of systemic lupus erythematosus. Clin Exp Rheumatol 23(5 Suppl 39):S120–S132PubMed Lam GK, Petri M (2005) Assessment of systemic lupus erythematosus. Clin Exp Rheumatol 23(5 Suppl 39):S120–S132PubMed
139.
Zurück zum Zitat Hasselaar P, Derksen RH, Blokzijl L, de Groot PG (1990) Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets. Thromb Haemost 63(2):169–173PubMed Hasselaar P, Derksen RH, Blokzijl L, de Groot PG (1990) Crossreactivity of antibodies directed against cardiolipin, DNA, endothelial cells and blood platelets. Thromb Haemost 63(2):169–173PubMed
140.
Zurück zum Zitat Lafer EM, Rauch J, Andrzejewski C Jr, Mudd D, Furie B, Furie B, Schwartz RS, Stollar BD (1981) Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med 153(4):897–909PubMed Lafer EM, Rauch J, Andrzejewski C Jr, Mudd D, Furie B, Furie B, Schwartz RS, Stollar BD (1981) Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med 153(4):897–909PubMed
141.
Zurück zum Zitat Manson JJ, Ma A, Rogers P, Mason LJ, Berden JH, van der Vlag J, D'Cruz DP, Isenberg DA, Rahman A (2009) Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study. Arthritis Res Ther 11(5):R154. doi:10.1186/ar2831 PubMedPubMedCentral Manson JJ, Ma A, Rogers P, Mason LJ, Berden JH, van der Vlag J, D'Cruz DP, Isenberg DA, Rahman A (2009) Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study. Arthritis Res Ther 11(5):R154. doi:10.​1186/​ar2831 PubMedPubMedCentral
142.
Zurück zum Zitat Koffler D, Schur PH, Kunkel HG (1967) Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med 126(4):607–624PubMedPubMedCentral Koffler D, Schur PH, Kunkel HG (1967) Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med 126(4):607–624PubMedPubMedCentral
143.
Zurück zum Zitat Isenberg DA (1997) Autoantibodies: markers of disease or pathogenic? Ann N Y Acad Sci 823:256–262PubMed Isenberg DA (1997) Autoantibodies: markers of disease or pathogenic? Ann N Y Acad Sci 823:256–262PubMed
144.
145.
Zurück zum Zitat Marion TN, Krishnan MR, Steeves MA, Desai DD (2003) Affinity maturation and autoimmunity to DNA. Curr Dir Autoimmun 6:123–153PubMed Marion TN, Krishnan MR, Steeves MA, Desai DD (2003) Affinity maturation and autoimmunity to DNA. Curr Dir Autoimmun 6:123–153PubMed
146.
Zurück zum Zitat Crow MK (2007) Type I interferon in systemic lupus erythematosus. Curr Top Microbiol Immunol 316:359–386PubMed Crow MK (2007) Type I interferon in systemic lupus erythematosus. Curr Top Microbiol Immunol 316:359–386PubMed
148.
Zurück zum Zitat Pascual V, Banchereau J, Palucka AK (2003) The central role of dendritic cells and interferon-alpha in SLE. Curr Opin Rheumatol 15(5):548–556PubMed Pascual V, Banchereau J, Palucka AK (2003) The central role of dendritic cells and interferon-alpha in SLE. Curr Opin Rheumatol 15(5):548–556PubMed
149.
Zurück zum Zitat Wofsy D, Seaman WE (1985) Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med 161(2):378–391PubMed Wofsy D, Seaman WE (1985) Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med 161(2):378–391PubMed
152.
Zurück zum Zitat Hsu HC, Yang P, Wang J, Wu Q, Myers R, Chen J, Yi J, Guentert T, Tousson A, Stanus AL, Le TV, Lorenz RG, Xu H, Kolls JK, Carter RH, Chaplin DD, Williams RW, Mountz JD (2008) Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9(2):166–175. doi:10.1038/ni1552 PubMed Hsu HC, Yang P, Wang J, Wu Q, Myers R, Chen J, Yi J, Guentert T, Tousson A, Stanus AL, Le TV, Lorenz RG, Xu H, Kolls JK, Carter RH, Chaplin DD, Williams RW, Mountz JD (2008) Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol 9(2):166–175. doi:10.​1038/​ni1552 PubMed
153.
Zurück zum Zitat Hochberg MC, Petri M (1993) Clinical features of systemic lupus erythematosus. Curr Opin Rheumatol 5(5):575–586PubMed Hochberg MC, Petri M (1993) Clinical features of systemic lupus erythematosus. Curr Opin Rheumatol 5(5):575–586PubMed
154.
Zurück zum Zitat Isenberg DA, Manson JJ, Ehrenstein MR, Rahman A (2007) Fifty years of anti-ds DNA antibodies: are we approaching journey's end? Rheumatology (Oxford) 46(7):1052–1056. doi:10.1093/rheumatology/kem112 Isenberg DA, Manson JJ, Ehrenstein MR, Rahman A (2007) Fifty years of anti-ds DNA antibodies: are we approaching journey's end? Rheumatology (Oxford) 46(7):1052–1056. doi:10.​1093/​rheumatology/​kem112
155.
Zurück zum Zitat Papadimitraki ED, Isenberg DA (2009) Childhood- and adult-onset lupus: an update of similarities and differences. Expert Rev Clin Immunol 5(4):391–403. doi:10.1586/eci.09.29 PubMed Papadimitraki ED, Isenberg DA (2009) Childhood- and adult-onset lupus: an update of similarities and differences. Expert Rev Clin Immunol 5(4):391–403. doi:10.​1586/​eci.​09.​29 PubMed
156.
Zurück zum Zitat Mellors RC, Ortega LG, Holman HR (1957) Role of gamma globulins in pathogenesis of renal lesions in systemic lupus erythematosus and chronic membranous glomerulonephritis, with an observation on the lupus erythematosus cell reaction. J Exp Med 106(2):191–202PubMedPubMedCentral Mellors RC, Ortega LG, Holman HR (1957) Role of gamma globulins in pathogenesis of renal lesions in systemic lupus erythematosus and chronic membranous glomerulonephritis, with an observation on the lupus erythematosus cell reaction. J Exp Med 106(2):191–202PubMedPubMedCentral
157.
Zurück zum Zitat Freedman P, Markowitz AS (1962) Isolation of antibody-like gamma-globulin from lupus glomeruli. Br Med J 1(5286):1175–1178PubMedPubMedCentral Freedman P, Markowitz AS (1962) Isolation of antibody-like gamma-globulin from lupus glomeruli. Br Med J 1(5286):1175–1178PubMedPubMedCentral
158.
Zurück zum Zitat Krishnan C, Kaplan MH (1967) Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis. J Clin Invest 46(4):569–579. doi:10.1172/JCI105558 PubMedPubMedCentral Krishnan C, Kaplan MH (1967) Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis. J Clin Invest 46(4):569–579. doi:10.​1172/​JCI105558 PubMedPubMedCentral
160.
Zurück zum Zitat Channing AA, Kasuga T, Horowitz RE, Dubois EL, Demopoulos HB (1965) An ultrastructural study of spontaneous lupus nephritis in the NZB-BL-NZW mouse. Am J Pathol 47(4):677–694PubMedPubMedCentral Channing AA, Kasuga T, Horowitz RE, Dubois EL, Demopoulos HB (1965) An ultrastructural study of spontaneous lupus nephritis in the NZB-BL-NZW mouse. Am J Pathol 47(4):677–694PubMedPubMedCentral
161.
Zurück zum Zitat Farquhar MG, Vernier RL, Good RA (1957) An electron microscope study of the glomerulus in nephrosis, glomerulonephritis, and lupus erythematosus. J Exp Med 106(5):649–660PubMedPubMedCentral Farquhar MG, Vernier RL, Good RA (1957) An electron microscope study of the glomerulus in nephrosis, glomerulonephritis, and lupus erythematosus. J Exp Med 106(5):649–660PubMedPubMedCentral
162.
Zurück zum Zitat Kalaaji M, Mortensen E, Jorgensen L, Olsen R, Rekvig OP (2006) Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells. Am J Pathol 168(6):1779–1792. doi:10.2353/ajpath.2006.051329 PubMedPubMedCentral Kalaaji M, Mortensen E, Jorgensen L, Olsen R, Rekvig OP (2006) Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells. Am J Pathol 168(6):1779–1792. doi:10.​2353/​ajpath.​2006.​051329 PubMedPubMedCentral
163.
Zurück zum Zitat Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ (1999) A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 189(10):1639–1648PubMedPubMedCentral Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ (1999) A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 189(10):1639–1648PubMedPubMedCentral
164.
Zurück zum Zitat Shlomchik MJ, Madaio MP, Ni D, Trounstein M, Huszar D (1994) The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med 180(4):1295–1306PubMed Shlomchik MJ, Madaio MP, Ni D, Trounstein M, Huszar D (1994) The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med 180(4):1295–1306PubMed
165.
Zurück zum Zitat Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV (1994) FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 76(3):519–529PubMed Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV (1994) FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 76(3):519–529PubMed
168.
Zurück zum Zitat Godau J, Heller T, Hawlisch H, Trappe M, Howells E, Best J, Zwirner J, Verbeek JS, Hogarth PM, Gerard C, Van Rooijen N, Klos A, Gessner JE, Kohl J (2004) C5a initiates the inflammatory cascade in immune complex peritonitis. J Immunol 173(5):3437–3445PubMed Godau J, Heller T, Hawlisch H, Trappe M, Howells E, Best J, Zwirner J, Verbeek JS, Hogarth PM, Gerard C, Van Rooijen N, Klos A, Gessner JE, Kohl J (2004) C5a initiates the inflammatory cascade in immune complex peritonitis. J Immunol 173(5):3437–3445PubMed
169.
Zurück zum Zitat Wang Y, Hu Q, Madri JA, Rollins SA, Chodera A, Matis LA (1996) Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc Natl Acad Sci U S A 93(16):8563–8568PubMedPubMedCentral Wang Y, Hu Q, Madri JA, Rollins SA, Chodera A, Matis LA (1996) Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc Natl Acad Sci U S A 93(16):8563–8568PubMedPubMedCentral
170.
Zurück zum Zitat Shushakova N, Skokowa J, Schulman J, Baumann U, Zwirner J, Schmidt RE, Gessner JE (2002) C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease. J Clin Invest 110(12):1823–1830. doi:10.1172/JCI16577 PubMedPubMedCentral Shushakova N, Skokowa J, Schulman J, Baumann U, Zwirner J, Schmidt RE, Gessner JE (2002) C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease. J Clin Invest 110(12):1823–1830. doi:10.​1172/​JCI16577 PubMedPubMedCentral
171.
Zurück zum Zitat Skokowa J, Ali SR, Felda O, Kumar V, Konrad S, Shushakova N, Schmidt RE, Piekorz RP, Nurnberg B, Spicher K, Birnbaumer L, Zwirner J, Claassens JW, Verbeek JS, van Rooijen N, Kohl J, Gessner JE (2005) Macrophages induce the inflammatory response in the pulmonary Arthus reaction through G alpha i2 activation that controls C5aR and Fc receptor cooperation. J Immunol 174(5):3041–3050PubMed Skokowa J, Ali SR, Felda O, Kumar V, Konrad S, Shushakova N, Schmidt RE, Piekorz RP, Nurnberg B, Spicher K, Birnbaumer L, Zwirner J, Claassens JW, Verbeek JS, van Rooijen N, Kohl J, Gessner JE (2005) Macrophages induce the inflammatory response in the pulmonary Arthus reaction through G alpha i2 activation that controls C5aR and Fc receptor cooperation. J Immunol 174(5):3041–3050PubMed
173.
Zurück zum Zitat Uciechowski P, Schwarz M, Gessner JE, Schmidt RE, Resch K, Radeke HH (1998) IFN-gamma induces the high-affinity Fc receptor I for IgG (CD64) on human glomerular mesangial cells. Eur J Immunol 28(9):2928–2935PubMed Uciechowski P, Schwarz M, Gessner JE, Schmidt RE, Resch K, Radeke HH (1998) IFN-gamma induces the high-affinity Fc receptor I for IgG (CD64) on human glomerular mesangial cells. Eur J Immunol 28(9):2928–2935PubMed
174.
Zurück zum Zitat Morcos M, Hansch GM, Schonermark M, Ellwanger S, Harle M, Heckl-Ostreicher B (1994) Human glomerular mesangial cells express CD16 and may be stimulated via this receptor. Kidney Int 46(6):1627–1634PubMed Morcos M, Hansch GM, Schonermark M, Ellwanger S, Harle M, Heckl-Ostreicher B (1994) Human glomerular mesangial cells express CD16 and may be stimulated via this receptor. Kidney Int 46(6):1627–1634PubMed
175.
Zurück zum Zitat Lopez-Armada MJ, Gomez-Guerrero C, Egido J (1996) Receptors for immune complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta. J Immunol 157(5):2136–2142PubMed Lopez-Armada MJ, Gomez-Guerrero C, Egido J (1996) Receptors for immune complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta. J Immunol 157(5):2136–2142PubMed
176.
Zurück zum Zitat Kanapathippillai P, Hedberg A, Fenton CG, Fenton KA (2013) Nucleosomes contribute to increase mesangial cell chemokine expression during the development of lupus nephritis. Cytokine 62(2):244–252. doi:10.1016/j.cyto.2013.03.016 PubMed Kanapathippillai P, Hedberg A, Fenton CG, Fenton KA (2013) Nucleosomes contribute to increase mesangial cell chemokine expression during the development of lupus nephritis. Cytokine 62(2):244–252. doi:10.​1016/​j.​cyto.​2013.​03.​016 PubMed
177.
Zurück zum Zitat Qing X, Zavadil J, Crosby MB, Hogarth MP, Hahn BH, Mohan C, Gilkeson GS, Bottinger EP, Putterman C (2006) Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum 54(7):2198–2210. doi:10.1002/art.21934 PubMed Qing X, Zavadil J, Crosby MB, Hogarth MP, Hahn BH, Mohan C, Gilkeson GS, Bottinger EP, Putterman C (2006) Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum 54(7):2198–2210. doi:10.​1002/​art.​21934 PubMed
178.
Zurück zum Zitat Radeke HH, Janssen-Graalfs I, Sowa EN, Chouchakova N, Skokowa J, Loscher F, Schmidt RE, Heeringa P, Gessner JE (2002) Opposite regulation of type II and III receptors for immunoglobulin G in mouse glomerular mesangial cells and in the induction of anti-glomerular basement membrane (GBM) nephritis. J Biol Chem 277(30):27535–27544. doi:10.1074/jbc.M200419200 PubMed Radeke HH, Janssen-Graalfs I, Sowa EN, Chouchakova N, Skokowa J, Loscher F, Schmidt RE, Heeringa P, Gessner JE (2002) Opposite regulation of type II and III receptors for immunoglobulin G in mouse glomerular mesangial cells and in the induction of anti-glomerular basement membrane (GBM) nephritis. J Biol Chem 277(30):27535–27544. doi:10.​1074/​jbc.​M200419200 PubMed
179.
Zurück zum Zitat Patole PS, Pawar RD, Lech M, Zecher D, Schmidt H, Segerer S, Ellwart A, Henger A, Kretzler M, Anders HJ (2006) Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice. Nephrol Dial Transplant 21(11):3062–3073. doi:10.1093/ndt/gfl336 PubMed Patole PS, Pawar RD, Lech M, Zecher D, Schmidt H, Segerer S, Ellwart A, Henger A, Kretzler M, Anders HJ (2006) Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice. Nephrol Dial Transplant 21(11):3062–3073. doi:10.​1093/​ndt/​gfl336 PubMed
180.
Zurück zum Zitat Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408(6813):740–745PubMed Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408(6813):740–745PubMed
181.
Zurück zum Zitat Bergtold A, Gavhane A, D'Agati V, Madaio M, Clynes R (2006) FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis. J Immunol 177(10):7287–7295PubMed Bergtold A, Gavhane A, D'Agati V, Madaio M, Clynes R (2006) FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis. J Immunol 177(10):7287–7295PubMed
183.
Zurück zum Zitat Jacob CO, van der Meide PH, McDevitt HO (1987) In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J Exp Med 166(3):798–803PubMed Jacob CO, van der Meide PH, McDevitt HO (1987) In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J Exp Med 166(3):798–803PubMed
184.
Zurück zum Zitat Bagavant H, Deshmukh US, Wang H, Ly T, Fu SM (2006) Role for nephritogenic T cells in lupus glomerulonephritis: progression to renal failure is accompanied by T cell activation and expansion in regional lymph nodes. J Immunol 177(11):8258–8265PubMed Bagavant H, Deshmukh US, Wang H, Ly T, Fu SM (2006) Role for nephritogenic T cells in lupus glomerulonephritis: progression to renal failure is accompanied by T cell activation and expansion in regional lymph nodes. J Immunol 177(11):8258–8265PubMed
188.
Zurück zum Zitat Ebling F, Hahn BH (1980) Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus. Comparison of antibodies in serum and renal eluates. Arthritis Rheum 23(4):392–403PubMed Ebling F, Hahn BH (1980) Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus. Comparison of antibodies in serum and renal eluates. Arthritis Rheum 23(4):392–403PubMed
189.
Zurück zum Zitat Gladman DD, Urowitz MB, Keystone EC (1979) Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serological features. Am J Med 66:210–215PubMed Gladman DD, Urowitz MB, Keystone EC (1979) Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serological features. Am J Med 66:210–215PubMed
190.
Zurück zum Zitat Madaio MP (1999) The role of autoantibodies in the pathogenesis of lupus nephritis. Semin Nephrol 19(1):48–56PubMed Madaio MP (1999) The role of autoantibodies in the pathogenesis of lupus nephritis. Semin Nephrol 19(1):48–56PubMed
191.
Zurück zum Zitat Ng KP, Manson JJ, Rahman A, Isenberg DA (2006) Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus. Arthritis Rheum 55(6):900–904. doi:10.1002/art.22356 PubMed Ng KP, Manson JJ, Rahman A, Isenberg DA (2006) Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus. Arthritis Rheum 55(6):900–904. doi:10.​1002/​art.​22356 PubMed
192.
Zurück zum Zitat Swaak AJ, Aarden LA, Statius van Eps LW, Feltkamp TE (1979) Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum 22(3):226–235PubMed Swaak AJ, Aarden LA, Statius van Eps LW, Feltkamp TE (1979) Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum 22(3):226–235PubMed
193.
Zurück zum Zitat Steeves MA, Marion TN (2004) Tolerance to DNA in (NZB x NZW)F1 mice that inherit an anti-DNA V(H) as a conventional micro H chain transgene but not as a V(H) knock-in transgene. J Immunol 172(11):6568–6577PubMed Steeves MA, Marion TN (2004) Tolerance to DNA in (NZB x NZW)F1 mice that inherit an anti-DNA V(H) as a conventional micro H chain transgene but not as a V(H) knock-in transgene. J Immunol 172(11):6568–6577PubMed
194.
Zurück zum Zitat Friedmann D, Yachimovich N, Mostoslavsky G, Pewzner-Jung Y, Ben-Yehuda A, Rajewsky K, Eilat D (1999) Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain. J Immunol 162(8):4406–4416PubMed Friedmann D, Yachimovich N, Mostoslavsky G, Pewzner-Jung Y, Ben-Yehuda A, Rajewsky K, Eilat D (1999) Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain. J Immunol 162(8):4406–4416PubMed
195.
Zurück zum Zitat Wellmann U, Letz M, Schneider A, Amann K, Winkler TH (2001) An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice. Int Immunol 13(12):1461–1469PubMed Wellmann U, Letz M, Schneider A, Amann K, Winkler TH (2001) An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice. Int Immunol 13(12):1461–1469PubMed
196.
Zurück zum Zitat Gilkeson GS, Bernstein K, Pippen AM, Clarke SH, Marion T, Pisetsky DS, Ruiz P, Lefkowith JB (1995) The influence of variable-region somatic mutations on the specificity and pathogenicity of murine monoclonal anti-DNA antibodies. Clin Immunol Immunopathol 76(1 Pt 1):59–67. doi:10.1006/clin.1995.1088 PubMed Gilkeson GS, Bernstein K, Pippen AM, Clarke SH, Marion T, Pisetsky DS, Ruiz P, Lefkowith JB (1995) The influence of variable-region somatic mutations on the specificity and pathogenicity of murine monoclonal anti-DNA antibodies. Clin Immunol Immunopathol 76(1 Pt 1):59–67. doi:10.​1006/​clin.​1995.​1088 PubMed
197.
Zurück zum Zitat Madaio MP, Carlson J, Cataldo J, Ucci A, Migliorini P, Pankewycz O (1987) Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits. J Immunol 138(9):2883–2889PubMed Madaio MP, Carlson J, Cataldo J, Ucci A, Migliorini P, Pankewycz O (1987) Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits. J Immunol 138(9):2883–2889PubMed
198.
Zurück zum Zitat Pankewycz OG, Migliorini P, Madaio MP (1987) Polyreactive autoantibodies are nephritogenic in murine lupus nephritis. J Immunol 139(10):3287–3294PubMed Pankewycz OG, Migliorini P, Madaio MP (1987) Polyreactive autoantibodies are nephritogenic in murine lupus nephritis. J Immunol 139(10):3287–3294PubMed
199.
Zurück zum Zitat Sabbaga J, Line SR, Potocnjak P, Madaio MP (1989) A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane. Eur J Immunol 19(1):137–143. doi:10.1002/eji.1830190122 PubMed Sabbaga J, Line SR, Potocnjak P, Madaio MP (1989) A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane. Eur J Immunol 19(1):137–143. doi:10.​1002/​eji.​1830190122 PubMed
200.
Zurück zum Zitat Raz E, Brezis M, Rosenmann E, Eilat D (1989) Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol 142(9):3076–3082PubMed Raz E, Brezis M, Rosenmann E, Eilat D (1989) Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol 142(9):3076–3082PubMed
201.
Zurück zum Zitat Kalaaji M, Fenton KA, Mortensen ES, Olsen R, Sturfelt G, Alm P, Rekvig OP (2007) Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int 71(7):664–672. doi:10.1038/sj.ki.5002133 PubMed Kalaaji M, Fenton KA, Mortensen ES, Olsen R, Sturfelt G, Alm P, Rekvig OP (2007) Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int 71(7):664–672. doi:10.​1038/​sj.​ki.​5002133 PubMed
202.
Zurück zum Zitat Fenton KA, Tommeras B, Marion TN, Rekvig OP (2010) Pure anti-dsDNA mAbs need chromatin structures to promote glomerular mesangial deposits in BALB/c mice. Autoimmunity 43(2):179–188. doi:10.3109/08916930903305633 PubMed Fenton KA, Tommeras B, Marion TN, Rekvig OP (2010) Pure anti-dsDNA mAbs need chromatin structures to promote glomerular mesangial deposits in BALB/c mice. Autoimmunity 43(2):179–188. doi:10.​3109/​0891693090330563​3 PubMed
203.
Zurück zum Zitat Kramers C, Hylkema MN, van Bruggen MC, van de Lagemaat R, Dijkman HB, Assmann KJ, Smeenk RJ, Berden JH (1994) Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest 94(2):568–577. doi:10.1172/JCI117371 PubMedPubMedCentral Kramers C, Hylkema MN, van Bruggen MC, van de Lagemaat R, Dijkman HB, Assmann KJ, Smeenk RJ, Berden JH (1994) Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo. J Clin Invest 94(2):568–577. doi:10.​1172/​JCI117371 PubMedPubMedCentral
204.
Zurück zum Zitat Izui S, Lambert PH, Miescher PA (1976) In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA. A possible basis for a local formation of DNA-anti-DNA complexes in systemic lupus erythematosus. J Exp Med 144(2):428–443PubMed Izui S, Lambert PH, Miescher PA (1976) In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA. A possible basis for a local formation of DNA-anti-DNA complexes in systemic lupus erythematosus. J Exp Med 144(2):428–443PubMed
205.
Zurück zum Zitat Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ (1997) Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389(6648):251–260. doi:10.1038/38444 PubMed Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ (1997) Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389(6648):251–260. doi:10.​1038/​38444 PubMed
206.
Zurück zum Zitat Schalch T, Duda S, Sargent DF, Richmond TJ (2005) X-ray structure of a tetranucleosome and its implications for the chromatin fibre. Nature 436(7047):138–141. doi:10.1038/nature03686 PubMed Schalch T, Duda S, Sargent DF, Richmond TJ (2005) X-ray structure of a tetranucleosome and its implications for the chromatin fibre. Nature 436(7047):138–141. doi:10.​1038/​nature03686 PubMed
207.
Zurück zum Zitat Materese CK, Savelyev A, Papoian GA (2009) Counterion atmosphere and hydration patterns near a nucleosome core particle. J Am Chem Soc 131(41):15005–15013. doi:10.1021/ja905376q PubMed Materese CK, Savelyev A, Papoian GA (2009) Counterion atmosphere and hydration patterns near a nucleosome core particle. J Am Chem Soc 131(41):15005–15013. doi:10.​1021/​ja905376q PubMed
208.
Zurück zum Zitat Caulfield JP, Farquhar MG (1976) Distribution of annionic sites in glomerular basement membranes: their possible role in filtration and attachment. Proc Natl Acad Sci U S A 73(5):1646–1650PubMedPubMedCentral Caulfield JP, Farquhar MG (1976) Distribution of annionic sites in glomerular basement membranes: their possible role in filtration and attachment. Proc Natl Acad Sci U S A 73(5):1646–1650PubMedPubMedCentral
209.
Zurück zum Zitat Kanwar YS, Farquhar MG (1979) Anionic sites in the glomerular basement membrane. In vivo and in vitro localization to the laminae rarae by cationic probes. J Cell Biol 81(1):137–153PubMed Kanwar YS, Farquhar MG (1979) Anionic sites in the glomerular basement membrane. In vivo and in vitro localization to the laminae rarae by cationic probes. J Cell Biol 81(1):137–153PubMed
210.
211.
Zurück zum Zitat Rumore P, Muralidhar B, Lin M, Lai C, Steinman CR (1992) Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance. Clin Exp Immunol 90(1):56–62PubMedPubMedCentral Rumore P, Muralidhar B, Lin M, Lai C, Steinman CR (1992) Haemodialysis as a model for studying endogenous plasma DNA: oligonucleosome-like structure and clearance. Clin Exp Immunol 90(1):56–62PubMedPubMedCentral
212.
Zurück zum Zitat Gauthier VJ, Tyler LN, Mannik M (1996) Blood clearance kinetics and liver uptake of mononucleosomes in mice. J Immunol 156(3):1151–1156PubMed Gauthier VJ, Tyler LN, Mannik M (1996) Blood clearance kinetics and liver uptake of mononucleosomes in mice. J Immunol 156(3):1151–1156PubMed
214.
Zurück zum Zitat Agodoa LY, Gauthier VJ, Mannik M (1985) Antibody localization in the glomerular basement membrane may precede in situ immune deposit formation in rat glomeruli. J Immunol 134(2):880–884PubMed Agodoa LY, Gauthier VJ, Mannik M (1985) Antibody localization in the glomerular basement membrane may precede in situ immune deposit formation in rat glomeruli. J Immunol 134(2):880–884PubMed
216.
Zurück zum Zitat Morshed M, Hlushchuk R, Simon D, Walls AF, Obata-Ninomiya K, Karasuyama H, Djonov V, Eggel A, Kaufmann T, Simon HU, Yousefi S (2014) NADPH oxidase-independent formation of extracellular DNA traps by basophils. J Immunol. doi:10.4049/jimmunol.1303418 PubMed Morshed M, Hlushchuk R, Simon D, Walls AF, Obata-Ninomiya K, Karasuyama H, Djonov V, Eggel A, Kaufmann T, Simon HU, Yousefi S (2014) NADPH oxidase-independent formation of extracellular DNA traps by basophils. J Immunol. doi:10.​4049/​jimmunol.​1303418 PubMed
217.
Zurück zum Zitat Cline AM, Radic MZ (2004) Murine lupus autoantibodies identify distinct subsets of apoptotic bodies. Autoimmunity 37(2):85–93PubMed Cline AM, Radic MZ (2004) Murine lupus autoantibodies identify distinct subsets of apoptotic bodies. Autoimmunity 37(2):85–93PubMed
219.
Zurück zum Zitat Gauthier VJ, Mannik M, Striker GE (1982) Effect of cationized antibodies in performed immune complexes on deposition and persistence in renal glomeruli. J Exp Med 156(3):766–777PubMed Gauthier VJ, Mannik M, Striker GE (1982) Effect of cationized antibodies in performed immune complexes on deposition and persistence in renal glomeruli. J Exp Med 156(3):766–777PubMed
220.
Zurück zum Zitat Schiffer L, Bethunaickan R, Ramanujam M, Huang W, Schiffer M, Tao H, Madaio MP, Bottinger EP, Davidson A (2008) Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol 180(3):1938–1947PubMedPubMedCentral Schiffer L, Bethunaickan R, Ramanujam M, Huang W, Schiffer M, Tao H, Madaio MP, Bottinger EP, Davidson A (2008) Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol 180(3):1938–1947PubMedPubMedCentral
222.
223.
Zurück zum Zitat Flier J, Boorsma DM, van Beek PJ, Nieboer C, Stoof TJ, Willemze R, Tensen CP (2001) Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 194(4):398–405PubMed Flier J, Boorsma DM, van Beek PJ, Nieboer C, Stoof TJ, Willemze R, Tensen CP (2001) Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 194(4):398–405PubMed
224.
Zurück zum Zitat Wenzel J, Zahn S, Mikus S, Wiechert A, Bieber T, Tuting T (2007) The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets. Br J Dermatol 157(4):752–757. doi:10.1111/j.1365-2133.2007.08137.x PubMed Wenzel J, Zahn S, Mikus S, Wiechert A, Bieber T, Tuting T (2007) The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets. Br J Dermatol 157(4):752–757. doi:10.​1111/​j.​1365-2133.​2007.​08137.​x PubMed
225.
Zurück zum Zitat Hofmann SC, Bosma A, Bruckner-Tuderman L, Vukmanovic-Stejic M, Jury EC, Isenberg DA, Mauri C (2013) Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus. J Dermatol Sci 71(1):22–28. doi:10.1016/j.jdermsci.2013.04.012 PubMed Hofmann SC, Bosma A, Bruckner-Tuderman L, Vukmanovic-Stejic M, Jury EC, Isenberg DA, Mauri C (2013) Invariant natural killer T cells are enriched at the site of cutaneous inflammation in lupus erythematosus. J Dermatol Sci 71(1):22–28. doi:10.​1016/​j.​jdermsci.​2013.​04.​012 PubMed
226.
Zurück zum Zitat Popovic K, Ek M, Espinosa A, Padyukov L, Harris HE, Wahren-Herlenius M, Nyberg F (2005) Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum 52(11):3639–3645. doi:10.1002/art.21398 PubMed Popovic K, Ek M, Espinosa A, Padyukov L, Harris HE, Wahren-Herlenius M, Nyberg F (2005) Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum 52(11):3639–3645. doi:10.​1002/​art.​21398 PubMed
228.
229.
Zurück zum Zitat Zahn S, Rehkamper C, Kummerer BM, Ferring-Schmidt S, Bieber T, Tuting T, Wenzel J (2011) Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFN-lambda) in cutaneous lupus erythematosus. J Invest Dermatol 131(1):133–140. doi:10.1038/jid.2010.244 PubMed Zahn S, Rehkamper C, Kummerer BM, Ferring-Schmidt S, Bieber T, Tuting T, Wenzel J (2011) Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFN-lambda) in cutaneous lupus erythematosus. J Invest Dermatol 131(1):133–140. doi:10.​1038/​jid.​2010.​244 PubMed
231.
Zurück zum Zitat Bennion SD, Norris DA (1997) Ultraviolet light modulation of autoantigens, epidermal cytokines and adhesion molecules as contributing factors of the pathogenesis of cutaneous LE. Lupus 6(2):181–192PubMed Bennion SD, Norris DA (1997) Ultraviolet light modulation of autoantigens, epidermal cytokines and adhesion molecules as contributing factors of the pathogenesis of cutaneous LE. Lupus 6(2):181–192PubMed
232.
Zurück zum Zitat Reefman E, Kuiper H, Limburg PC, Kallenberg CG, Bijl M (2008) Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients. Ann Rheum Dis 67(1):11–18. doi:10.1136/ard.2007.070359 PubMed Reefman E, Kuiper H, Limburg PC, Kallenberg CG, Bijl M (2008) Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients. Ann Rheum Dis 67(1):11–18. doi:10.​1136/​ard.​2007.​070359 PubMed
233.
234.
Zurück zum Zitat Uehara T, Xi Peng X, Bennett B, Satoh Y, Friedman G, Currin R, Brenner DA, Lemasters J (2004) c-Jun N-terminal kinase mediates hepatic injury after rat liver transplantation. Transplantation 78(3):324–332PubMed Uehara T, Xi Peng X, Bennett B, Satoh Y, Friedman G, Currin R, Brenner DA, Lemasters J (2004) c-Jun N-terminal kinase mediates hepatic injury after rat liver transplantation. Transplantation 78(3):324–332PubMed
236.
Zurück zum Zitat Caricchio R, McPhie L, Cohen PL (2003) Ultraviolet B radiation-induced cell death: critical role of ultraviolet dose in inflammation and lupus autoantigen redistribution. J Immunol 171(11):5778–5786PubMed Caricchio R, McPhie L, Cohen PL (2003) Ultraviolet B radiation-induced cell death: critical role of ultraviolet dose in inflammation and lupus autoantigen redistribution. J Immunol 171(11):5778–5786PubMed
237.
Zurück zum Zitat Korhonen R, Linker K, Pautz A, Forstermann U, Moilanen E, Kleinert H (2007) Post-transcriptional regulation of human inducible nitric-oxide synthase expression by the Jun N-terminal kinase. Mol Pharmacol 71(5):1427–1434. doi:10.1124/mol.106.033449 PubMed Korhonen R, Linker K, Pautz A, Forstermann U, Moilanen E, Kleinert H (2007) Post-transcriptional regulation of human inducible nitric-oxide synthase expression by the Jun N-terminal kinase. Mol Pharmacol 71(5):1427–1434. doi:10.​1124/​mol.​106.​033449 PubMed
238.
Zurück zum Zitat Suschek CV, Krischel V, Bruch-Gerharz D, Berendji D, Krutmann J, Kroncke KD, Kolb-Bachofen V (1999) Nitric oxide fully protects against UVA-induced apoptosis in tight correlation with Bcl-2 up-regulation. J Biol Chem 274(10):6130–6137PubMed Suschek CV, Krischel V, Bruch-Gerharz D, Berendji D, Krutmann J, Kroncke KD, Kolb-Bachofen V (1999) Nitric oxide fully protects against UVA-induced apoptosis in tight correlation with Bcl-2 up-regulation. J Biol Chem 274(10):6130–6137PubMed
239.
Zurück zum Zitat Kuhn A, Fehsel K, Lehmann P, Krutmann J, Ruzicka T, Kolb-Bachofen V (1998) Aberrant timing in epidermal expression of inducible nitric oxide synthase after UV irradiation in cutaneous lupus erythematosus. J Invest Dermatol 111(1):149–153. doi:10.1046/j.1523-1747.1998.00253.x PubMed Kuhn A, Fehsel K, Lehmann P, Krutmann J, Ruzicka T, Kolb-Bachofen V (1998) Aberrant timing in epidermal expression of inducible nitric oxide synthase after UV irradiation in cutaneous lupus erythematosus. J Invest Dermatol 111(1):149–153. doi:10.​1046/​j.​1523-1747.​1998.​00253.​x PubMed
241.
Zurück zum Zitat Yokogawa M, Takaishi M, Nakajima K, Kamijima R, Fujimoto C, Kataoka S, Terada Y, Sano S (2014) Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic lupus erythematosus. Arthritis & Rheumatol 66(3):694–706. doi:10.1002/art.38298 Yokogawa M, Takaishi M, Nakajima K, Kamijima R, Fujimoto C, Kataoka S, Terada Y, Sano S (2014) Epicutaneous application of toll-like receptor 7 agonists leads to systemic autoimmunity in wild-type mice: a new model of systemic lupus erythematosus. Arthritis & Rheumatol 66(3):694–706. doi:10.​1002/​art.​38298
242.
Zurück zum Zitat Zamora MR, Warner ML, Tuder R, Schwarz MI (1997) Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 76(3):192–202 Zamora MR, Warner ML, Tuder R, Schwarz MI (1997) Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 76(3):192–202
243.
Zurück zum Zitat Hunninghake GW, Fauci AS (1979) Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis 119(3):471–503PubMed Hunninghake GW, Fauci AS (1979) Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis 119(3):471–503PubMed
244.
Zurück zum Zitat Emlen W (1993) Systemic lupus erythematosus and mixed connective tissue disease. Immunol Allergy Clin N Am 13(2):291–311 Emlen W (1993) Systemic lupus erythematosus and mixed connective tissue disease. Immunol Allergy Clin N Am 13(2):291–311
248.
Zurück zum Zitat Santos-Ocampo AS, Mandell BF, Fessler BJ (2000) Alveolar hemorrhage in systemic lupus erythematosus: presentation and management. Chest 118(4):1083–1090PubMed Santos-Ocampo AS, Mandell BF, Fessler BJ (2000) Alveolar hemorrhage in systemic lupus erythematosus: presentation and management. Chest 118(4):1083–1090PubMed
249.
Zurück zum Zitat Marino CT, Pertschuk LP (1981) Pulmonary hemorrhage in systemic lupus erythematosus. Arch Intern Med 141(2):201–203PubMed Marino CT, Pertschuk LP (1981) Pulmonary hemorrhage in systemic lupus erythematosus. Arch Intern Med 141(2):201–203PubMed
250.
Zurück zum Zitat Travis WD, Colby TV, Lombard C, Carpenter HA (1990) A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol 14(12):1112–1125PubMed Travis WD, Colby TV, Lombard C, Carpenter HA (1990) A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol 14(12):1112–1125PubMed
252.
Zurück zum Zitat Leatherman JW (1987) Immune alveolar hemorrhage. Chest 91(6):891–897PubMed Leatherman JW (1987) Immune alveolar hemorrhage. Chest 91(6):891–897PubMed
253.
Zurück zum Zitat Myers JL, Katzenstein AA (1986) Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 85(5):552–556PubMed Myers JL, Katzenstein AA (1986) Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 85(5):552–556PubMed
254.
Zurück zum Zitat Schwab EP, Schumacher HR Jr, Freundlich B, Callegari PE (1993) Pulmonary alveolar hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 23(1):8–15PubMed Schwab EP, Schumacher HR Jr, Freundlich B, Callegari PE (1993) Pulmonary alveolar hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 23(1):8–15PubMed
255.
Zurück zum Zitat Nellessen CM, Poge U, Brensing KA, Sauerbruch T, Klehr HU, Rabe C (2008) Diffuse alveolar haemorrhage in a systemic lupus erythematosus patient successfully treated with rituximab: a case report. Nephrol Dial Transplant 23(1):385–386. doi:10.1093/ndt/gfm701 PubMed Nellessen CM, Poge U, Brensing KA, Sauerbruch T, Klehr HU, Rabe C (2008) Diffuse alveolar haemorrhage in a systemic lupus erythematosus patient successfully treated with rituximab: a case report. Nephrol Dial Transplant 23(1):385–386. doi:10.​1093/​ndt/​gfm701 PubMed
256.
Zurück zum Zitat Badsha H, Teh CL, Kong KO, Lian TY, Chng HH (2004) Pulmonary hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 33(6):414–421PubMed Badsha H, Teh CL, Kong KO, Lian TY, Chng HH (2004) Pulmonary hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 33(6):414–421PubMed
257.
Zurück zum Zitat Esmaeilbeigi F, Juvet S, Hwang D, Mittoo S (2012) Desquamative interstitial pneumonitis in a patient with systemic lupus erythematosus. Can Respir J : J Can Thoracic Soc 19(1):50–52 Esmaeilbeigi F, Juvet S, Hwang D, Mittoo S (2012) Desquamative interstitial pneumonitis in a patient with systemic lupus erythematosus. Can Respir J : J Can Thoracic Soc 19(1):50–52
258.
Zurück zum Zitat Haupt HM, Moore GW, Hutchins GM (1981) The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med 71(5):791–798PubMed Haupt HM, Moore GW, Hutchins GM (1981) The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med 71(5):791–798PubMed
259.
Zurück zum Zitat Matthay RA, Schwarz MI, Petty TL, Stanford RE, Gupta RC, Sahn SA, Steigerwald JC (1975) Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) 54(5):397–409 Matthay RA, Schwarz MI, Petty TL, Stanford RE, Gupta RC, Sahn SA, Steigerwald JC (1975) Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) 54(5):397–409
260.
Zurück zum Zitat Cervera R, Font J, Pare C, Azqueta M, Perez-Villa F, Lopez-Soto A, Ingelmo M (1992) Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 51(2):156–159PubMedPubMedCentral Cervera R, Font J, Pare C, Azqueta M, Perez-Villa F, Lopez-Soto A, Ingelmo M (1992) Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 51(2):156–159PubMedPubMedCentral
261.
Zurück zum Zitat Law WG, Thong BY, Lian TY, Kong KO, Chng HH (2005) Acute lupus myocarditis: clinical features and outcome of an oriental case series. Lupus 14(10):827–831PubMed Law WG, Thong BY, Lian TY, Kong KO, Chng HH (2005) Acute lupus myocarditis: clinical features and outcome of an oriental case series. Lupus 14(10):827–831PubMed
262.
Zurück zum Zitat Nihoyannopoulos P, Gomez PM, Joshi J, Loizou S, Walport MJ, Oakley CM (1990) Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation 82(2):369–375PubMed Nihoyannopoulos P, Gomez PM, Joshi J, Loizou S, Walport MJ, Oakley CM (1990) Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation 82(2):369–375PubMed
263.
Zurück zum Zitat Crozier IG, Li E, Milne MJ, Nicholls MG (1990) Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol 65(16):1145–1148PubMed Crozier IG, Li E, Milne MJ, Nicholls MG (1990) Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol 65(16):1145–1148PubMed
264.
Zurück zum Zitat Sturfelt G, Eskilsson J, Nived O, Truedsson L, Valind S (1992) Cardiovascular disease in systemic lupus erythematosus. A study of 75 patients form a defined population. Medicine (Baltimore) 71(4):216–223 Sturfelt G, Eskilsson J, Nived O, Truedsson L, Valind S (1992) Cardiovascular disease in systemic lupus erythematosus. A study of 75 patients form a defined population. Medicine (Baltimore) 71(4):216–223
266.
Zurück zum Zitat Castier MB, Albuquerque EM, Menezes ME, Klumb E, Albanesi Filho FM (2000) Cardiac tamponade in systemic lupus erythematosus. Report of four cases. Arq Bras Cardiol 75(5):446–448PubMed Castier MB, Albuquerque EM, Menezes ME, Klumb E, Albanesi Filho FM (2000) Cardiac tamponade in systemic lupus erythematosus. Report of four cases. Arq Bras Cardiol 75(5):446–448PubMed
267.
Zurück zum Zitat Goldenber D (1973) Pericardial-fluid complement. Ann Intern Med 78(5):786PubMed Goldenber D (1973) Pericardial-fluid complement. Ann Intern Med 78(5):786PubMed
268.
Zurück zum Zitat Doherty NE, Siegel RJ (1985) Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 110(6):1257–1265PubMed Doherty NE, Siegel RJ (1985) Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 110(6):1257–1265PubMed
269.
Zurück zum Zitat Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH (1954) Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 33(4):291–437 Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH (1954) Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 33(4):291–437
270.
Zurück zum Zitat Badui E, Garcia-Rubi D, Robles E, Jimenez J, Juan L, Deleze M, Diaz A, Mintz G (1985) Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 36(7):431–441PubMed Badui E, Garcia-Rubi D, Robles E, Jimenez J, Juan L, Deleze M, Diaz A, Mintz G (1985) Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 36(7):431–441PubMed
271.
Zurück zum Zitat Estes D, Christian CL (1971) The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 50(2):85–95 Estes D, Christian CL (1971) The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 50(2):85–95
272.
Zurück zum Zitat Bulkley BH, Roberts WC (1975) The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am J Med 58(2):243–264PubMed Bulkley BH, Roberts WC (1975) The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am J Med 58(2):243–264PubMed
273.
Zurück zum Zitat Esscher E, Scott JS (1979) Congenital heart block and maternal systemic lupus erythematosus. Br Med J 1(6173):1235–1238PubMedPubMedCentral Esscher E, Scott JS (1979) Congenital heart block and maternal systemic lupus erythematosus. Br Med J 1(6173):1235–1238PubMedPubMedCentral
274.
Zurück zum Zitat Buyon JP, Ben-Chetrit E, Karp S, Roubey RA, Pompeo L, Reeves WH, Tan EM, Winchester R (1989) Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus. J Clin Invest 84(2):627–634. doi:10.1172/JCI114208 PubMedPubMedCentral Buyon JP, Ben-Chetrit E, Karp S, Roubey RA, Pompeo L, Reeves WH, Tan EM, Winchester R (1989) Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus. J Clin Invest 84(2):627–634. doi:10.​1172/​JCI114208 PubMedPubMedCentral
275.
Zurück zum Zitat Derksen RH, Meilof JF (1992) Anti-Ro/SS-A and anti-La/SS-B autoantibody levels in relation to systemic lupus erythematosus disease activity and congenital heart block. A longitudinal study comprising two consecutive pregnancies in a patient with systemic lupus erythematosus. Arthritis Rheum 35(8):953–959PubMed Derksen RH, Meilof JF (1992) Anti-Ro/SS-A and anti-La/SS-B autoantibody levels in relation to systemic lupus erythematosus disease activity and congenital heart block. A longitudinal study comprising two consecutive pregnancies in a patient with systemic lupus erythematosus. Arthritis Rheum 35(8):953–959PubMed
276.
Zurück zum Zitat Fritsch C, Hoebeke J, Dali H, Ricchiuti V, Isenberg DA, Meyer O, Muller S (2006) 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block. Arthritis Res & Ther 8(1):R4. doi:10.1186/ar1848 Fritsch C, Hoebeke J, Dali H, Ricchiuti V, Isenberg DA, Meyer O, Muller S (2006) 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block. Arthritis Res & Ther 8(1):R4. doi:10.​1186/​ar1848
277.
Zurück zum Zitat Reed BR, Lee LA, Harmon C, Wolfe R, Wiggins J, Peebles C, Weston WL (1983) Autoantibodies to SS-A/Ro in infants with congenital heart block. J Pediatr 103(6):889–891PubMed Reed BR, Lee LA, Harmon C, Wolfe R, Wiggins J, Peebles C, Weston WL (1983) Autoantibodies to SS-A/Ro in infants with congenital heart block. J Pediatr 103(6):889–891PubMed
279.
281.
Zurück zum Zitat D'Alton JG, Preston DN, Bormanis J, Green MS, Kraag GR (1985) Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis. Stroke 16(3):512–514PubMed D'Alton JG, Preston DN, Bormanis J, Green MS, Kraag GR (1985) Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis. Stroke 16(3):512–514PubMed
282.
Zurück zum Zitat Bidani AK, Roberts JL, Schwartz MM, Lewis EJ (1980) Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 69(6):849–858PubMed Bidani AK, Roberts JL, Schwartz MM, Lewis EJ (1980) Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 69(6):849–858PubMed
283.
Zurück zum Zitat Ziporen L, Goldberg I, Arad M, Hojnik M, Ordi-Ros J, Afek A, Blank M, Sandbank Y, Vilardell-Tarres M, de Torres I, Weinberger A, Asherson RA, Kopolovic Y, Shoenfeld Y (1996) Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus 5(3):196–205PubMed Ziporen L, Goldberg I, Arad M, Hojnik M, Ordi-Ros J, Afek A, Blank M, Sandbank Y, Vilardell-Tarres M, de Torres I, Weinberger A, Asherson RA, Kopolovic Y, Shoenfeld Y (1996) Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus 5(3):196–205PubMed
285.
Zurück zum Zitat Fesmire J, Wolfson-Reichlin M, Reichlin M (2010) Effects of autoimmune antibodies anti-lipoprotein lipase, anti-low density lipoprotein, and anti-oxidized low density lipoprotein on lipid metabolism and atherosclerosis in systemic lupus erythematosus. Rev Bras Reumatol 50(5):539–551PubMedPubMedCentral Fesmire J, Wolfson-Reichlin M, Reichlin M (2010) Effects of autoimmune antibodies anti-lipoprotein lipase, anti-low density lipoprotein, and anti-oxidized low density lipoprotein on lipid metabolism and atherosclerosis in systemic lupus erythematosus. Rev Bras Reumatol 50(5):539–551PubMedPubMedCentral
286.
Zurück zum Zitat O'Neill SG, Giles I, Lambrianides A, Manson J, D'Cruz D, Schrieber L, March LM, Latchman DS, Isenberg DA, Rahman A (2010) Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 62(3):845–854. doi:10.1002/art.27286 PubMed O'Neill SG, Giles I, Lambrianides A, Manson J, D'Cruz D, Schrieber L, March LM, Latchman DS, Isenberg DA, Rahman A (2010) Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 62(3):845–854. doi:10.​1002/​art.​27286 PubMed
287.
Zurück zum Zitat Cieslik P, Hrycek A, Klucinski P (2008) Vasculopathy and vasculitis in systemic lupus erythematosus. Pol Arch Med Wewn 118(1–2):57–63PubMed Cieslik P, Hrycek A, Klucinski P (2008) Vasculopathy and vasculitis in systemic lupus erythematosus. Pol Arch Med Wewn 118(1–2):57–63PubMed
289.
Zurück zum Zitat Ramos-Casals M, Nardi N, Lagrutta M, Brito-Zeron P, Bove A, Delgado G, Cervera R, Ingelmo M, Font J (2006) Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine (Baltimore) 85(2):95–104. doi:10.1097/01.md.0000216817.35937.70 Ramos-Casals M, Nardi N, Lagrutta M, Brito-Zeron P, Bove A, Delgado G, Cervera R, Ingelmo M, Font J (2006) Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine (Baltimore) 85(2):95–104. doi:10.​1097/​01.​md.​0000216817.​35937.​70
291.
Zurück zum Zitat Matsumoto T, Kobayashi S, Shimizu H, Nakajima M, Watanabe S, Kitami N, Sato N, Abe H, Aoki Y, Hoshi T, Hashimoto H (2000) The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver. Liver 20(5):366–373PubMed Matsumoto T, Kobayashi S, Shimizu H, Nakajima M, Watanabe S, Kitami N, Sato N, Abe H, Aoki Y, Hoshi T, Hashimoto H (2000) The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver. Liver 20(5):366–373PubMed
292.
Zurück zum Zitat Swanepoel CR, Floyd A, Allison H, Learmonth GM, Cassidy MJ, Pascoe MD (1983) Acute acalculous cholecystitis complicating systemic lupus erythematosus: case report and review. Br Med J (Clin Res Ed) 286(6361):251–252 Swanepoel CR, Floyd A, Allison H, Learmonth GM, Cassidy MJ, Pascoe MD (1983) Acute acalculous cholecystitis complicating systemic lupus erythematosus: case report and review. Br Med J (Clin Res Ed) 286(6361):251–252
293.
294.
Zurück zum Zitat Ashouri JF, Davis JL, Farkas A, Durack JC, Ramachandran R, Dall'Era M (2012) A young woman with systemic lupus erythematosus and extensive mesenteric vasculitis involving small and medium vessels. Arthritis Care Res (Hoboken) 64(12):1928–1933. doi:10.1002/acr.21833 Ashouri JF, Davis JL, Farkas A, Durack JC, Ramachandran R, Dall'Era M (2012) A young woman with systemic lupus erythematosus and extensive mesenteric vasculitis involving small and medium vessels. Arthritis Care Res (Hoboken) 64(12):1928–1933. doi:10.​1002/​acr.​21833
295.
Zurück zum Zitat Weisman MH, McDanald EC, Wilson CB (1981) Studies of the pathogenesis of interstitial cystitis, obstructive uropathy, and intestinal malabsorption in a patient with systemic lupus erythematosus. Am J Med 70(4):875–881PubMed Weisman MH, McDanald EC, Wilson CB (1981) Studies of the pathogenesis of interstitial cystitis, obstructive uropathy, and intestinal malabsorption in a patient with systemic lupus erythematosus. Am J Med 70(4):875–881PubMed
296.
Zurück zum Zitat Geri G, Saadoun D, Guillevin R, Crozier S, Lubetzki C, Mokhtari K, Amoura Z, Wechsler B, Le Boutin D, Costedoat-Chalumeau N, Samson Y, Cacoub P (2014) Central nervous system angiitis: a series of 31 patients. Clin Rheumatol 33(1):105–110. doi:10.1007/s10067-013-2403-3 PubMed Geri G, Saadoun D, Guillevin R, Crozier S, Lubetzki C, Mokhtari K, Amoura Z, Wechsler B, Le Boutin D, Costedoat-Chalumeau N, Samson Y, Cacoub P (2014) Central nervous system angiitis: a series of 31 patients. Clin Rheumatol 33(1):105–110. doi:10.​1007/​s10067-013-2403-3 PubMed
297.
Zurück zum Zitat Sun W, Jiao Y, Cui B, Gao X, Xia Y, Zhao Y (2013) Immune complexes activate human endothelium involving the cell-signaling HMGB1-RAGE axis in the pathogenesis of lupus vasculitis. Lab Invest 93(6):626–638. doi:10.1038/labinvest.2013.61 PubMed Sun W, Jiao Y, Cui B, Gao X, Xia Y, Zhao Y (2013) Immune complexes activate human endothelium involving the cell-signaling HMGB1-RAGE axis in the pathogenesis of lupus vasculitis. Lab Invest 93(6):626–638. doi:10.​1038/​labinvest.​2013.​61 PubMed
298.
Zurück zum Zitat Sciascia S, Bertolaccini ML, Baldovino S, Roccatello D, Khamashta MA, Sanna G (2013) Central nervous system involvement in systemic lupus erythematosus: overview on classification criteria. Autoimmun Rev 12(3):426–429. doi:10.1016/j.autrev.2012.08.014 PubMed Sciascia S, Bertolaccini ML, Baldovino S, Roccatello D, Khamashta MA, Sanna G (2013) Central nervous system involvement in systemic lupus erythematosus: overview on classification criteria. Autoimmun Rev 12(3):426–429. doi:10.​1016/​j.​autrev.​2012.​08.​014 PubMed
299.
Zurück zum Zitat Borowoy AM, Pope JE, Silverman E, Fortin PR, Pineau C, Smith CD, Arbillaga H, Gladman D, Urowitz M, Zummer M, Hudson M, Tucker L, Peschken C (2012) Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Semin Arthritis Rheum 42(2):179–185. doi:10.1016/j.semarthrit.2012.03.011 PubMed Borowoy AM, Pope JE, Silverman E, Fortin PR, Pineau C, Smith CD, Arbillaga H, Gladman D, Urowitz M, Zummer M, Hudson M, Tucker L, Peschken C (2012) Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Semin Arthritis Rheum 42(2):179–185. doi:10.​1016/​j.​semarthrit.​2012.​03.​011 PubMed
301.
Zurück zum Zitat Bosma GP, Middelkoop HA, Rood MJ, Bollen EL, Huizinga TW, van Buchem MA (2002) Association of global brain damage and clinical functioning in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 46(10):2665–2672. doi:10.1002/art.10574 PubMed Bosma GP, Middelkoop HA, Rood MJ, Bollen EL, Huizinga TW, van Buchem MA (2002) Association of global brain damage and clinical functioning in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 46(10):2665–2672. doi:10.​1002/​art.​10574 PubMed
305.
Zurück zum Zitat Luyendijk J, Steens SC, Ouwendijk WJ, Steup-Beekman GM, Bollen EL, van der Grond J, Huizinga TW, Emmer BJ, van Buchem MA (2011) Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging. Arthritis Rheum 63(3):722–732. doi:10.1002/art.30157 PubMed Luyendijk J, Steens SC, Ouwendijk WJ, Steup-Beekman GM, Bollen EL, van der Grond J, Huizinga TW, Emmer BJ, van Buchem MA (2011) Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging. Arthritis Rheum 63(3):722–732. doi:10.​1002/​art.​30157 PubMed
306.
Zurück zum Zitat Nobili F, Mignone A, Rossi E, Morbelli S, Piccardo A, Puppo F, Indiveri F, Sambuceti G, Rodriguez G (2006) Migraine during systemic lupus erythematosus: findings from brain single photon emission computed tomography. J Rheumatol 33(11):2184–2191PubMed Nobili F, Mignone A, Rossi E, Morbelli S, Piccardo A, Puppo F, Indiveri F, Sambuceti G, Rodriguez G (2006) Migraine during systemic lupus erythematosus: findings from brain single photon emission computed tomography. J Rheumatol 33(11):2184–2191PubMed
307.
Zurück zum Zitat Zhang X, Zhu Z, Zhang F, Shu H, Li F, Dong Y (2005) Diagnostic value of single-photon-emission computed tomography in severe central nervous system involvement of systemic lupus erythematosus: a case–control study. Arthritis Rheum 53(6):845–849. doi:10.1002/art.21591 PubMed Zhang X, Zhu Z, Zhang F, Shu H, Li F, Dong Y (2005) Diagnostic value of single-photon-emission computed tomography in severe central nervous system involvement of systemic lupus erythematosus: a case–control study. Arthritis Rheum 53(6):845–849. doi:10.​1002/​art.​21591 PubMed
308.
Zurück zum Zitat Appenzeller S, Amorim BJ, Ramos CD, Rio PA, de Etchebehere EC, Camargo EE, Cendes F, Costallat LT (2007) Voxel-based morphometry of brain SPECT can detect the presence of active central nervous system involvement in systemic lupus erythematosus. Rheumatology (Oxford) 46(3):467–472. doi:10.1093/rheumatology/kel255 Appenzeller S, Amorim BJ, Ramos CD, Rio PA, de Etchebehere EC, Camargo EE, Cendes F, Costallat LT (2007) Voxel-based morphometry of brain SPECT can detect the presence of active central nervous system involvement in systemic lupus erythematosus. Rheumatology (Oxford) 46(3):467–472. doi:10.​1093/​rheumatology/​kel255
310.
Zurück zum Zitat Axford JS, Howe FA, Heron C, Griffiths JR (2001) Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus. Ann Rheum Dis 60(2):106–111PubMedPubMedCentral Axford JS, Howe FA, Heron C, Griffiths JR (2001) Sensitivity of quantitative (1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus. Ann Rheum Dis 60(2):106–111PubMedPubMedCentral
311.
Zurück zum Zitat Trysberg E, Nylen K, Rosengren LE, Tarkowski A (2003) Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum 48(10):2881–2887. doi:10.1002/art.11279 PubMed Trysberg E, Nylen K, Rosengren LE, Tarkowski A (2003) Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum 48(10):2881–2887. doi:10.​1002/​art.​11279 PubMed
312.
Zurück zum Zitat Kwiecinski J, Klak M, Trysberg E, Blennow K, Tarkowski A, Jin T (2009) Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 60(7):2094–2101. doi:10.1002/art.24603 PubMed Kwiecinski J, Klak M, Trysberg E, Blennow K, Tarkowski A, Jin T (2009) Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 60(7):2094–2101. doi:10.​1002/​art.​24603 PubMed
313.
Zurück zum Zitat Gono T, Kawaguchi Y, Kaneko H, Nishimura K, Hanaoka M, Kataoka S, Okamoto Y, Katsumata Y, Yamanaka H (2011) Anti-NR2A antibody as a predictor for neuropsychiatric systemic lupus erythematosus. Rheumatology (Oxford) 50(9):1578–1585. doi:10.1093/rheumatology/keq408 Gono T, Kawaguchi Y, Kaneko H, Nishimura K, Hanaoka M, Kataoka S, Okamoto Y, Katsumata Y, Yamanaka H (2011) Anti-NR2A antibody as a predictor for neuropsychiatric systemic lupus erythematosus. Rheumatology (Oxford) 50(9):1578–1585. doi:10.​1093/​rheumatology/​keq408
314.
Zurück zum Zitat Lefranc D, Launay D, Dubucquoi S, de Seze J, Dussart P, Vermersch M, Hachulla E, Hatron PY, Vermersch P, Mouthon L, Prin L (2007) Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach. Arthritis Rheum 56(10):3420–3432. doi:10.1002/art.22863 PubMed Lefranc D, Launay D, Dubucquoi S, de Seze J, Dussart P, Vermersch M, Hachulla E, Hatron PY, Vermersch P, Mouthon L, Prin L (2007) Characterization of discriminant human brain antigenic targets in neuropsychiatric systemic lupus erythematosus using an immunoproteomic approach. Arthritis Rheum 56(10):3420–3432. doi:10.​1002/​art.​22863 PubMed
315.
Zurück zum Zitat Ndhlovu M, Preuss BE, Dengjel J, Stevanovic S, Weiner SM, Klein R (2011) Identification of alpha-tubulin as an autoantigen recognized by sera from patients with neuropsychiatric systemic lupus erythematosus. Brain Behav Immun 25(2):279–285. doi:10.1016/j.bbi.2010.09.019 PubMed Ndhlovu M, Preuss BE, Dengjel J, Stevanovic S, Weiner SM, Klein R (2011) Identification of alpha-tubulin as an autoantigen recognized by sera from patients with neuropsychiatric systemic lupus erythematosus. Brain Behav Immun 25(2):279–285. doi:10.​1016/​j.​bbi.​2010.​09.​019 PubMed
316.
Zurück zum Zitat Galeazzi M, Annunziata P, Sebastiani GD, Bellisai F, Campanella V, Ferrara GB, Font J, Houssiau F, Passiu G, De Ramon GE, Fernandez-Nebro A, Bracci L, Scorza R, Puddu P, Jedryka-Goral A, Smolen J, Tincani A, Carcassi C, Morozzi G, Marcolongo R (2000) Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. European Concerted Action on the Immunogenetics of SLE The Journal of rheumatology 27(1):135–141 Galeazzi M, Annunziata P, Sebastiani GD, Bellisai F, Campanella V, Ferrara GB, Font J, Houssiau F, Passiu G, De Ramon GE, Fernandez-Nebro A, Bracci L, Scorza R, Puddu P, Jedryka-Goral A, Smolen J, Tincani A, Carcassi C, Morozzi G, Marcolongo R (2000) Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. European Concerted Action on the Immunogenetics of SLE The Journal of rheumatology 27(1):135–141
317.
Zurück zum Zitat Sanna G, Piga M, Terryberry JW, Peltz MT, Giagheddu S, Satta L, Ahmed A, Cauli A, Montaldo C, Passiu G, Peter JB, Shoenfeld Y, Mathieu A (2000) Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus 9(8):573–583PubMed Sanna G, Piga M, Terryberry JW, Peltz MT, Giagheddu S, Satta L, Ahmed A, Cauli A, Montaldo C, Passiu G, Peter JB, Shoenfeld Y, Mathieu A (2000) Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus 9(8):573–583PubMed
318.
Zurück zum Zitat Afeltra A, Garzia P, Mitterhofer AP, Vadacca M, Galluzzo S, Del Porto F, Finamore L, Pascucci S, Gasparini M, Lagana B, Caccavo D, Ferri GM, Amoroso A, Francia A (2003) Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology 61(1):108–110PubMed Afeltra A, Garzia P, Mitterhofer AP, Vadacca M, Galluzzo S, Del Porto F, Finamore L, Pascucci S, Gasparini M, Lagana B, Caccavo D, Ferri GM, Amoroso A, Francia A (2003) Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology 61(1):108–110PubMed
319.
Zurück zum Zitat Hanly JG, Urowitz MB, Siannis F, Farewell V, Gordon C, Bae SC, Isenberg D, Dooley MA, Clarke A, Bernatsky S, Gladman D, Fortin PR, Manzi S, Steinsson K, Bruce IN, Ginzler E, Aranow C, Wallace DJ, Ramsey-Goldman R, van Vollenhoven R, Sturfelt G, Nived O, Sanchez-Guerrero J, Alarcon GS, Petri M, Khamashta M, Zoma A, Font J, Kalunian K, Douglas J, Qi Q, Thompson K, Merrill JT (2008) Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum 58(3):843–853. doi:10.1002/art.23218 PubMed Hanly JG, Urowitz MB, Siannis F, Farewell V, Gordon C, Bae SC, Isenberg D, Dooley MA, Clarke A, Bernatsky S, Gladman D, Fortin PR, Manzi S, Steinsson K, Bruce IN, Ginzler E, Aranow C, Wallace DJ, Ramsey-Goldman R, van Vollenhoven R, Sturfelt G, Nived O, Sanchez-Guerrero J, Alarcon GS, Petri M, Khamashta M, Zoma A, Font J, Kalunian K, Douglas J, Qi Q, Thompson K, Merrill JT (2008) Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum 58(3):843–853. doi:10.​1002/​art.​23218 PubMed
320.
Zurück zum Zitat Meroni PL, Tincani A, Sepp N, Raschi E, Testoni C, Corsini E, Cavazzana I, Pellegrini S, Salmaggi A (2003) Endothelium and the brain in CNS lupus. Lupus 12(12):919–928PubMed Meroni PL, Tincani A, Sepp N, Raschi E, Testoni C, Corsini E, Cavazzana I, Pellegrini S, Salmaggi A (2003) Endothelium and the brain in CNS lupus. Lupus 12(12):919–928PubMed
322.
323.
Zurück zum Zitat Jurencak R, Fritzler M, Tyrrell P, Hiraki L, Benseler S, Silverman E (2009) Autoantibodies in pediatric systemic lupus erythematosus: ethnic grouping, cluster analysis, and clinical correlations. J Rheumatol 36(2):416–421. doi:10.3899/jrheum.080588 PubMed Jurencak R, Fritzler M, Tyrrell P, Hiraki L, Benseler S, Silverman E (2009) Autoantibodies in pediatric systemic lupus erythematosus: ethnic grouping, cluster analysis, and clinical correlations. J Rheumatol 36(2):416–421. doi:10.​3899/​jrheum.​080588 PubMed
324.
Zurück zum Zitat Sun XY, Shi J, Han L, Su Y, Li ZG (2008) Anti-histones antibodies in systemic lupus erythematosus: prevalence and frequency in neuropsychiatric lupus. J Clin Lab Anal 22(4):271–277. doi:10.1002/jcla.20248 PubMed Sun XY, Shi J, Han L, Su Y, Li ZG (2008) Anti-histones antibodies in systemic lupus erythematosus: prevalence and frequency in neuropsychiatric lupus. J Clin Lab Anal 22(4):271–277. doi:10.​1002/​jcla.​20248 PubMed
325.
328.
Zurück zum Zitat Baraczka K, Nekam K, Pozsonyi T, Jakab L, Szongoth M, Sesztak M (2001) Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement. Neuroimmunomodulation 9(1):49–54PubMed Baraczka K, Nekam K, Pozsonyi T, Jakab L, Szongoth M, Sesztak M (2001) Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement. Neuroimmunomodulation 9(1):49–54PubMed
329.
Zurück zum Zitat Baraczka K, Nekam K, Pozsonyi T, Szuts I, Ormos G (2004) Investigation of cytokine (tumor necrosis factor-alpha, interleukin-6, interleukin-10) concentrations in the cerebrospinal fluid of female patients with multiple sclerosis and systemic lupus erythematosus. Eur J Neurol 11(1):37–42PubMed Baraczka K, Nekam K, Pozsonyi T, Szuts I, Ormos G (2004) Investigation of cytokine (tumor necrosis factor-alpha, interleukin-6, interleukin-10) concentrations in the cerebrospinal fluid of female patients with multiple sclerosis and systemic lupus erythematosus. Eur J Neurol 11(1):37–42PubMed
330.
Zurück zum Zitat Katsumata Y, Harigai M, Kawaguchi Y, Fukasawa C, Soejima M, Takagi K, Tanaka M, Ichida H, Tochimoto A, Kanno T, Nishimura K, Kamatani N, Hara M (2007) Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin. J Rheumatol 34(10):2010–2017PubMed Katsumata Y, Harigai M, Kawaguchi Y, Fukasawa C, Soejima M, Takagi K, Tanaka M, Ichida H, Tochimoto A, Kanno T, Nishimura K, Kamatani N, Hara M (2007) Diagnostic reliability of cerebral spinal fluid tests for acute confusional state (delirium) in patients with systemic lupus erythematosus: interleukin 6 (IL-6), IL-8, interferon-alpha, IgG index, and Q-albumin. J Rheumatol 34(10):2010–2017PubMed
331.
Zurück zum Zitat Trysberg E, Carlsten H, Tarkowski A (2000) Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus 9(7):498–503PubMed Trysberg E, Carlsten H, Tarkowski A (2000) Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus 9(7):498–503PubMed
332.
Zurück zum Zitat Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narvaez A, Davila-Maldonado L, Atisha-Fregoso Y, Llorente L, Sanchez-Guerrero J (2007) Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 56(4):1242–1250. doi:10.1002/art.22451 PubMed Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narvaez A, Davila-Maldonado L, Atisha-Fregoso Y, Llorente L, Sanchez-Guerrero J (2007) Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 56(4):1242–1250. doi:10.​1002/​art.​22451 PubMed
333.
Zurück zum Zitat Svenungsson E, Andersson M, Brundin L, van Vollenhoven R, Khademi M, Tarkowski A, Greitz D, Dahlstrom M, Lundberg I, Klareskog L, Olsson T (2001) Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus. Ann Rheum Dis 60(4):372–379PubMedPubMedCentral Svenungsson E, Andersson M, Brundin L, van Vollenhoven R, Khademi M, Tarkowski A, Greitz D, Dahlstrom M, Lundberg I, Klareskog L, Olsson T (2001) Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus. Ann Rheum Dis 60(4):372–379PubMedPubMedCentral
334.
Zurück zum Zitat Trysberg E, Tarkowski A (2004) Cerebral inflammation and degeneration in systemic lupus erythematosus. Curr Opin Rheumatol 16(5):527–533PubMed Trysberg E, Tarkowski A (2004) Cerebral inflammation and degeneration in systemic lupus erythematosus. Curr Opin Rheumatol 16(5):527–533PubMed
335.
Zurück zum Zitat Tomita M, Holman BJ, Williams LS, Pang KC, Santoro TJ (2001) Cerebellar dysfunction is associated with overexpression of proinflammatory cytokine genes in lupus. J Neurosci Res 64(1):26–33PubMed Tomita M, Holman BJ, Williams LS, Pang KC, Santoro TJ (2001) Cerebellar dysfunction is associated with overexpression of proinflammatory cytokine genes in lupus. J Neurosci Res 64(1):26–33PubMed
336.
Zurück zum Zitat Mondal TK, Saha SK, Miller VM, Seegal RF, Lawrence DA (2008) Autoantibody-mediated neuroinflammation: pathogenesis of neuropsychiatric systemic lupus erythematosus in the NZM88 murine model. Brain Behav Immun 22(6):949–959. doi:10.1016/j.bbi.2008.01.013 PubMed Mondal TK, Saha SK, Miller VM, Seegal RF, Lawrence DA (2008) Autoantibody-mediated neuroinflammation: pathogenesis of neuropsychiatric systemic lupus erythematosus in the NZM88 murine model. Brain Behav Immun 22(6):949–959. doi:10.​1016/​j.​bbi.​2008.​01.​013 PubMed
337.
341.
Zurück zum Zitat Alexander JJ, Jacob A, Bao L, Macdonald RL, Quigg RJ (2005) Complement-dependent apoptosis and inflammatory gene changes in murine lupus cerebritis. J Immunol 175(12):8312–8319PubMed Alexander JJ, Jacob A, Bao L, Macdonald RL, Quigg RJ (2005) Complement-dependent apoptosis and inflammatory gene changes in murine lupus cerebritis. J Immunol 175(12):8312–8319PubMed
342.
Zurück zum Zitat Alexander JJ, Bao L, Jacob A, Kraus DM, Holers VM, Quigg RJ (2003) Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis. Biochim Biophys Acta 1639(3):169–176PubMed Alexander JJ, Bao L, Jacob A, Kraus DM, Holers VM, Quigg RJ (2003) Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis. Biochim Biophys Acta 1639(3):169–176PubMed
343.
Zurück zum Zitat Alexander JJ, Jacob A, Vezina P, Sekine H, Gilkeson GS, Quigg RJ (2007) Absence of functional alternative complement pathway alleviates lupus cerebritis. Eur J Immunol 37(6):1691–1701. doi:10.1002/eji.200636638 PubMed Alexander JJ, Jacob A, Vezina P, Sekine H, Gilkeson GS, Quigg RJ (2007) Absence of functional alternative complement pathway alleviates lupus cerebritis. Eur J Immunol 37(6):1691–1701. doi:10.​1002/​eji.​200636638 PubMed
344.
Zurück zum Zitat Ainiala H, Hietaharju A, Dastidar P, Loukkola J, Lehtimaki T, Peltola J, Korpela M, Heinonen T, Nikkari ST (2004) Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities. Arthritis Rheum 50(3):858–865. doi:10.1002/art.20045 PubMed Ainiala H, Hietaharju A, Dastidar P, Loukkola J, Lehtimaki T, Peltola J, Korpela M, Heinonen T, Nikkari ST (2004) Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities. Arthritis Rheum 50(3):858–865. doi:10.​1002/​art.​20045 PubMed
345.
Zurück zum Zitat Voulgarelis M, Kokori SI, Ioannidis JP, Tzioufas AG, Kyriaki D, Moutsopoulos HM (2000) Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin. Ann Rheum Dis 59(3):217–222PubMedPubMedCentral Voulgarelis M, Kokori SI, Ioannidis JP, Tzioufas AG, Kyriaki D, Moutsopoulos HM (2000) Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin. Ann Rheum Dis 59(3):217–222PubMedPubMedCentral
346.
Zurück zum Zitat Schett G, Firbas U, Fureder W, Hiesberger H, Winkler S, Wachauer D, Koller M, Kapiotis S, Smolen J (2001) Decreased serum erythropoietin and its relation to anti-erythropoietin antibodies in anaemia of systemic lupus erythematosus. Rheumatology (Oxford) 40(4):424–431 Schett G, Firbas U, Fureder W, Hiesberger H, Winkler S, Wachauer D, Koller M, Kapiotis S, Smolen J (2001) Decreased serum erythropoietin and its relation to anti-erythropoietin antibodies in anaemia of systemic lupus erythematosus. Rheumatology (Oxford) 40(4):424–431
347.
Zurück zum Zitat Garcia-Valladares I, Atisha-Fregoso Y, Richaud-Patin Y, Jakez-Ocampo J, Soto-Vega E, Elias-Lopez D, Carrillo-Maravilla E, Cabiedes J, Ruiz-Arguelles A, Llorente L (2006) Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia. Lupus 15(9):600–605PubMed Garcia-Valladares I, Atisha-Fregoso Y, Richaud-Patin Y, Jakez-Ocampo J, Soto-Vega E, Elias-Lopez D, Carrillo-Maravilla E, Cabiedes J, Ruiz-Arguelles A, Llorente L (2006) Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia. Lupus 15(9):600–605PubMed
349.
Zurück zum Zitat Midgley A, McLaren Z, Moots RJ, Edwards SW, Beresford MW (2009) The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 60(8):2390–2401. doi:10.1002/art.24634 PubMed Midgley A, McLaren Z, Moots RJ, Edwards SW, Beresford MW (2009) The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 60(8):2390–2401. doi:10.​1002/​art.​24634 PubMed
350.
351.
Zurück zum Zitat Enami T, Suzuki T, Ito S, Yoshimi A, Sugihara M, Mamura M, Hayashi T, Goto D, Matsumoto I, Tsutsumi A, Sumida T (2007) Successful treatment of refractory thrombotic thrombocytopenic purpura with cyclosporine and corticosteroids in a patient with systemic lupus erythematosus and antibodies to ADAMTS13. Intern Med 46(13):1033–1037PubMed Enami T, Suzuki T, Ito S, Yoshimi A, Sugihara M, Mamura M, Hayashi T, Goto D, Matsumoto I, Tsutsumi A, Sumida T (2007) Successful treatment of refractory thrombotic thrombocytopenic purpura with cyclosporine and corticosteroids in a patient with systemic lupus erythematosus and antibodies to ADAMTS13. Intern Med 46(13):1033–1037PubMed
Metadaten
Titel
Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus
verfasst von
Tony N. Marion
Arnold E. Postlethwaite
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Seminars in Immunopathology / Ausgabe 5/2014
Print ISSN: 1863-2297
Elektronische ISSN: 1863-2300
DOI
https://doi.org/10.1007/s00281-014-0440-x

Weitere Artikel der Ausgabe 5/2014

Seminars in Immunopathology 5/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.